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Foreword
The causal relationship between tobacco use generally, cigarette
smoking in particular, and disease is well documented in the
scientific literature. In 1982, the U.S. Surgeon General noted
that 350,000 excess deaths would be attributable each year to
tobacco use. Despite two decades of national efforts to prevent
the initiation of smoking by teenagers and other susceptible groups
and to treat the behavior of those already dependent on tobacco, 53
million Americans continue to smoke cigarettes. We still have
close to the highest per capita consumption of cigarettes in the
world.
In the past, the National Institute on Drug Abuse has examined
diverse aspects of smoking behavior (NIDA Research Monographs, No.
17--Research on Smoking Behavior; No. ES--Cigarette Smoking as a
Dependence Process; No. 26--The Behavioral Aspects of Smoking).
This volume adds a new dimension directing attention to issues,
methodologies, and technologies in smoking research design and
measurement.
The complex multifaceted aspects of smoking behavior include
research on pharmacological, physiological, behavioral, and
environmental determinants implicated in development, maintenance,
cessation, and relapse. The diversity of subject matter and
contributing factors necessitates reliance on equally varied
scientific resources. This, at times, results in conflicting
research strategies, designs, methodologies, and analytic
techniques. The present volume provides an overview of the state
of knowledge in the area and suggests general guidelines which when
applied could lead to increased validity, compatibility, and hence
comparability of data across studies. Attention to these factors
will lead to improved intervention and prevention techniques which
should eventually be reflected in reduction of tobacco-related
mortality and morbidity.
Finally, it is worthy of note that this volume represents the
result of collaborative efforts of two institutes, the National
Institute on Drug Abuse and the National Cancer Institute, and thus
emphasizes the need, desirability, and future opportunities for
joint efforts in resolution of tobacco-use related health problems.
William Pollin, M.D.
Director
National Institute on Drug Abuse
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Preface
The National Institute on Drug Abuse (NIDA) and the National Cancer
Institute (NCI) are devoted to contributing to disease prevention
and health promotion. Basic and applied research are important to
both Institutes. Each is involved in treatment and demonstration
programs designed to further their respective goals in the health
fields. Underlying many such efforts is the need for reliable
information which emanates from field, clinical, and laboratory
research supported by the Institutes.
Elucidation of the determinants of tobacco use is, of course, an
interdisciplinary effort. Integrated research brings with it the
weaknesses, as well as the strengths, of the respective
disciplines. In addition new and innovative techniques are often
required. A variety of technological advances have evolved in
research concerning tobacco use. However, fundamental problems
still exist concerning surveys, measurement, and topography of
smoking behavior. Therefore. in August 1982. NIDA and NCI convened
a group of scientists to address these issues. It was anticipated
that the benefits of such a review would be twofold. First,
improved techniques in survey, measurement, and topographical
analysis, would significantly enhance our research programs. This
will ultimately lead to improvements in treatment, prevention, and
health promotion. The second major benefit would derive from the
successful development of a research model in cigarette smoking
with stringent criteria for outcome and evaluation variables. In
turn this model might facilitate research in other areas involving
interactive behavioral and physiological problems.
The present volume is a summary of that meeting. While problems in
measurement still exist, careful study of and attention to the
crucial methodological issues raised should significantly enhance
our research activities. In addition, this volume provides a
strong indication of future directions as well as an examination of
many significant issues relevant to improving efforts in research
devoted to health and behavior.
Marvin Snyder, Ph.D.
Director
Division of Preclinical Research
National Institute on Drug Abuse
Alcohol, Drug Abuse, and Mental
Health Administration
Joseph Cullen, Ph.D.
Deputy Director
Division of Resources,
Centers, and Community
Activities
National Cancer Institute
National Institutes of Health
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Overview of Smoking
Research Issues
Catherine S. Bell, M.S., and John Grabowski, Ph.D.
Historically it is evident that drug use in its varied forms has
occurred in essentially all cultures. Control of use derived from
social, religious, and legal sanctions. Occasionally a drug has
been introduced and gained broad distribution free of governing
social or legal rules, and perturbations worthy of note have
followed. Thus, for example, the widespread introduction of opium
to China by the British generated years of social, economic, and
political problems. Concomitant efforts to eliminate use were
equally noteworthy.
Similarly, tobacco was introduced to Europe from the Americas in
the 16th century. Nicotine doses administered, typically by pipe,
chewing, or sniffing appeared not to involve substantial direct
disruptive behavioral or physiological effects. Smoking behavior
in particular, however, generated great distress in some circles.
Early on, King James I put forth his Counter Blaste to Tobacco (in
1604), which derogated tobacco and the user alike. Nevertheless,
tobacco use spread, and while the dominant dosage form (e.g.,
snuff, pipe, cigarettes) was subject to change, the upward trend
continued.
Efforts to terminate use and claims of dire health consequences
increased over several centuries. Concurrently, introduction of an
inexpensive dosage form, the machine-rolled cigarette, and new
tobacco curing techniques contributed dramatically to increased
use. Thus, the two forces, economic and health, pursued each other
in an upward spiral to the present time when both have considerable
power and notoriety. The tobacco industry reaps billions of
dollars annually. In addition the Federal Government supports a
substantial, although not comparable health maintenance,
prevention, and research effort. In the midst of this is the basic
effort to better understand the phenomena associated with tobacco
use.
It is apparent that the divergent positions concerning tobacco use
have an extended history. Data have only gradually accrued to
strongly support the long hypothesized relationships between
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tobacco use and ill health. In addition to reports from other
sources, those from behavioral pharmacology laboratories have
recently clarified the historically stated similarities between
diverse forms of drug use and tobacco use. Thus, this perspective
and current scientific wisdom now converge and point to future
needs and directions.
DESIGN ISSUES
Although examination of diverse aspects of tobacco use has been a
goal of government health and safety agencies, academic
institutions, and voluntary health agencies, there has been little
unanimity or agreement in certain areas. Thus, for example, widely
varying theoretical frameworks exist, as they do in many areas of
behavioral, biobehavioral, and biological science. This may well
be healthy and contribute to integrative models applicable to other
disorders, but only if such integration is actively pursued. In
addition, comparability of methodology and identification of
subject populations is often lacking. There currently exists a
need to identify known discrepancies or inconsistencies in research
design and analysis. Contributing to this problem are the all too
frequent research reports that fail to explain how smoking
behaviors are measured and verified. Interestingly, the
specificity and quality of measurement appear to decline as the
analysis moves from the laboratory, animal or human, to such
diverse settings as clinics and classrooms or the natural
environment. An even greater lack of measurement precision may
emerge when survey and related community intervention techniques
are employed despite increasing availability of new and appropriate
technologies. There is a general sense that inherent problems in
differing environments can be circumvented.
Loss of valuable information occurs when limited or no data are
provided concerning determinants of smoking rate, abstinence,
relapse, or shifts in tobacco dosage form used. Scientists and
clinicians alike have noted that the lack of consistent
application of measurement techniques has retarded progress in the
acquisition of systematic knowledge which could advance
understanding of smoking behavior and hence the development of
effective treatment techniques. In part, this has been due to
failure to draw attention to unifying or standardized approaches.
Nonetheless it is particularly disturbing in those areas where
laboratory research has provided tools essential to this effort.
Past problems with evaluation in smoking and tobacco research have
existed in design research and validation of treatment results.
More specifically, for example, there have been validation problems
resulting from unverified self-report of smoking behavior. Some
units of measurement have perhaps contributed to further
uncertainty. For example, preference for reporting packs of
cigarettes rather than number of cigarettes smoked may have led
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to assumptions dictating that a difficult "breakpoint" for smoking
exists at 10 cigarettes per day based on reports of half-pack
increments. In other cases absence of essential measures may
occur. For example, failure to obtain adequate baseline data,
including brand history, and a lack of information on individual
smoking styles, e.g., topography and dosimetry issues is not
uncommon. The inability to clearly relate correlates of outcome to
independent treatment variables may also result from other problems
including: (1) lack of controls and systematic design, (2) lack of
validation of programs developed in the research setting, (3) lack
of longitudinal data, (4) small n samples with excessive
variability in resultant data, (5) or when small n designs were
appropriate, insufficient replications of measures and, (6) lack of
attention to accepted theoretical guidelines or unifying conceptual
premises. In brief, some research in smoking and tobacco use has
perhaps in one sense suffered due to its divergent origins.
Concurrently it should be clear that exceptional research of
excellence has also been forthcoming. This has been particularly
true in recent years, although measurements problems do exist.
THE SCIENCE BACKGROUND
In the way of background on these issues, it is interesting to note
that few, if any, researchers have been trained in "cigarette
smoking research." To do so would, of course, result in
researchers who have little utility or scope with respect to other
issues. Rather, and appropriately, scientists converged from
diverse extant disciplines to contribute to a better understanding
of specialized problems which have facets in biochemistry,
physiology, neurological function, individual behavior, and,
finally, rather complex aspects of social behavior. Inter-
disciplinary efforts have thus emerged. While it is not clear that
"smoking researchers," per se, are needed, it is essential to
develop professionals whose skills bridge the gap of traditional
disciplines. Such bridging would permit thorough analysis of
biobehavioral disorders, especially
physiological and behavioral components.
those with multifaceted
CONVERGENCE
As the area of biobehavioral smoking research began to coalesce, it
became apparent that tobacco use could on one hand be examined as
another form of drug self-administration and that on the other hand
it might have characteristics in common with other behaviorally
based disorders. Thus, a search for similarities with other
behaviors and forms of drug use might provide a useful model for
analysis and for generating successful smoking prevention and
cessation programs.
In turn, refinement of the view dictated that tobacco use be
examined in the context of repetitive, stereotypic, habitual
behaviors of all sorts, ranging from gambling, to eating behavior,
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to dependence on alcohol and drugs, and even to excessive social
interaction needs. Indeed, it appeared that the general features
which characterized behavioral dependence were translatable across
many forms of so-called habitual behaviors.
SMOKING RESEARCH AS A BEHAVIORALLY BASED INTERDISCIPLINARY ENDEAVOR
It is evident that a plethora of clearly definable disease states
are correlated with and perhaps causally related to the use of
tobacco. Therefore, as previously noted, numerous scientific
groups became involved in the research effort from the laboratory
to treatment and prevention settings. Interestingly, objective
consideration suggests that even the disease states do not make the
smoking issues substantially different from other behavioral
problems which have often had their own associated physical ills.
However, it is the occurrence of specific disease states that has
generated the interest of many in what is fundamentally an issue of
drug self-administration.
In any case, it is clear that smoking behavior is of
interdisciplinary interest, and it is equally clear that various
scientists have developed specialized, different, and often
incompatible measures and have brought them to bear on the problems
associated with cigarette smoking and tobacco use. Unfortunately,
as has been suggested, there are areas in which standardized
strategies for research have not emerged.
Overall there is a need to identify and delineate available
measures and perhaps consider general principles if not guidelines
per se for measurement in the smoking research. The guidelines for
measurement of smoking behavior may also directly or indirectly
have some utility in defining goals for more effective prevention
and treatment strategies.
A systematic data collection strategy could provide a roughly
hierarchical sequence by which data could be obtained and results
defined and would also assure some equivalence in the data
collected. It is therefore important to determine what the minimal
level of acceptable data is in various settings or when examining
particular issues. The following provides an example: it might be
generally agreed that a study is of little value if it simply
posits the question "Do you smoke?" What, however, is the minimal
level of data to be obtained, and what makes asking any question
worthwhile, if there is an interest in approximating the notion of
dose effect or dose response? In brief, it is apparent that the
topic of interest is one which involves biobehavioral aspects and
that it is appropriate to suspect that an adequate array of
biological and behavioral measures is desirable if a study is to
have general utility. While it is clear that the degree of
precision in measurement may vary as a function of research goals,
it is equally apparent that the current level of inquiry requires
4
greater precision and strength than is frequently evident.
SUMMARY
Overall, the issue is deceptively simple. There is a need to list
the extant techniques which include some extensive recent
advances. This should be followed by a simple heirarchical
systematization of the techniques and definition of the requirments
of each category of study. As is evident in the present volume,
problems emerge in this effort. Nevertheless, it is clear that the
effort could have considerable benefit, and further that it might
serve as a model for biobehavioral research efforts. The present
volume and its contributors provide many, though not all, of the
essential ingredients, in an effort to move in this direction.
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The Use Of Biologic Fluid
Samples In Assessing
Tobacco Smoke Consumption
Neal L. Benowitz, M.D.
INTRODUCTION
Tobacco smoke consists of a mixture of combustion gases carrying
a suspension of particulate matter. Among the many components of
the gas phase arecarbon monoxide andhydrogen cyanide. Carbon
monoxide and serum thiocyanate, the latter a metabolite of hydro-
gen cyanide, are potentially useful markers of smoke consumption.
The particulate phase consists of nicotine and minor tobacco alka-
loids and, the remainder, termed tar. Measurements of nicotine
and its major metabolite cotinine are potentially useful markers
of nicotine exposure and intake. Quantitating tar consumption is
more difficult: indirect measurements such as measurement of
urinary excretion of polycyclic aromatic hydrocarbons and their
metabolites and of urinary mutagenic activity may prove to be
useful markers but are not yet ready to be applied to large-scale
smoking studies.
In this paper, I will focus on the use of carbon monoxide, thio-
cyanate, nicotine, and cotinine as markers of smoke consumption.
Factors influencing absorption of these substances from smoke,
elimination from the body, kinetic characteristics that relate to
their usefulness as markers of smoke exposure, and limitations of
their use are discussed.
Before discussing the individual compounds, it should be empha-
sized that 1) the relative intake of different pharmacologically
active substances differs among different tobacco products and
different smokers and 2) intake cannot be equated with exposure.
With respect to the latter, both rate of intake (dose) and rate
of elimination determine the average exposure level.. For these
reasons, selection of biochemical measurements must be dictated
by the hypotheses being tested. For example, studies of nicotine
self-administration should include measurements of nicotine and/
or cotinine. Studies of cardiovascular complications of smoking
should include measurements of carbon monoxide as well. Studies
of carcinogenesis require measurements of carcinogen exposure.
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CARBON MONOXIDE
As estimated by smoking machines, approximately 10 to 20 ml of
carbon monoxide is delivered to the smoker's mouth with each
cigarette. Delivery to the mouth depends on the characteristics
of the cigarette, particularly ventilation and moisture content,
and how the cigarette is smoked. Carbon monoxide is absorbed in
the lungs, where it diffuses across alveolar membranes. It is
not appreciably absorbed across mucous membranes or bronchioles.
Thus, depth of inhalation and the presence or absence of pulmon-
ary disease influence the absorption of a given dose of inhaled
carbon monoxide.
TABLE 1
Carbon monoxide
Dose 10-20 ml/cigarette
Varies with ventilation and misture
characteristics and how cigarette
is smoked
Absorption Pulmonary alveoli
Elimination Respiratory
Half-life 2-5 hours
Ventilation (activity) dependent
Measurement Spectrophotometric: Carboxyhemoglobin
Expired carbon monoxide
Within the body, carbon monoxide is bound, as is oxygen, to hemo-
globin, where it can be measured as carboxyhemoglobin. Carbon
monoxide may also be bound to myoglobin and the cytochrome enzyme
system, although quantitative details of binding to the latter
sites are as yet poorly defined. Carbon monoxide is eliminated
primarily by respiration. The rate of respiration determines the
rate of elimination. Thus, the half-life of carbon monoxide
during exercise may be less than 1 hour whereas during sleep it
may be greater than 8 hours (Castleden and Cole 1974). With
sedentary activity, the half-life is usually 3 to 4 hours.
The disposition kinetics of carbon monoxide are useful in under-
standing the time course of carbon monoxide in the body through-
out the smoking day. With a half-life averaging 4 hours, based
on pharmacokinetic principles one would predict that, with
reasonably constant dosing (that is, regular smoking rate),
carbon monoxide levels would plateau after 9 to 12 hours of
cigarette smoking. This is what we observed in circadian studies
of carboxyhemoglobin concentrations in cigarette smokers smoking
on a research ward (figure 1). There is a small increment and
decline in carboxyhemoglobin immediately after smoking individual
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FIGURE 1
BLOOD NICOTINE AND CARBOXYHEMOGLOBIN
CONCENTRATION WHILE SMOKING USUAL BRAND,
LOW (0.4mg) AND HIGH (2.5mg) NICOTINE CIGARETTES
CLOCK TIME
Blood nicotine and carboxyhemoglobin concentrations in subjects
smoking high-nicotine (2.5 mg) and low-nicotine (0.4 mg) Kentucky
reference cigarettes and their usual brand (average nicotine
yield 1.2 mg) of cigarettes. Subjects smoked on a fixed schedule
of 1 cigarette every half-hour from 8:30 A.M. to 11:00 P.M. for a
total of 30 cigarettes per day. Blood samples were collected
just before the next scheduled cigarette (figure taken from
Benowitz et al. 1982b). © 1982, The C.V. Mosby Company.
Reprinted by permission.
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cigarettes (not shown in figure 1), but after several hours of
smoking the magnitude of the rise and fall is small compared with
the trough values. Thus, sampling carboxyhemoglobin at the end
of a smoking day is a reasonably good indicator of the daily CO
exposure.
Because of reduced ventilation during sleep, the rate of elimina-
tion of carbon monoxide is slower at night than during the day.
With an overnight half-life of 5-9 hours (Castleden and Cole
1974), carbon monoxide persists in the body at substantial levels
throughout the night &spite no further smoking (figure 1). In
our subjects, carboxyhemoglobin concentrations averaged 4-5 per-
cent before smoking the first cigarette of the day. Thus, the
toxic effects of carbon monoxide in smokers are not only experi-
enced in proximity to smoking, but also persist for 24 hours of
every day. Morning carbon monoxide measurements are sensitive to
cigarette smoking, but probably provide less quantitative inform-
ation about the magnitude of daily exposure than do afternoon
levels.
The usefulness of carbon monoxide as a measurement of tobacco
smoke consumption can be considered in terms of specificity,
sensitivity, and limitations. Specificity refers to the prob-
ability that a nonsmoker will be classified as a nonsmoker.
Thus, a highly specific measurement has a low rate of classify-
ing nonsmokers as smokers. In most cases, carbon monoxide
levels, when measured at the end of the smoking day, are specific
for cigarette smoking. There is an endogenous CO concentration
(carboxyhemoglobin of about 0.7 percent) that is much lower than
that observed in cigarette smokers. However, employment in
areas with high ambient carbon monoxide concentrations, exposure
to methylene chloride, which is metabolized to carbon monoxide
(Stewart et al. 1972), or driving on busy freeways (Aronow et al.
1972) may also reduce the specificity of carbon monoxide levels,
particularly when studying light smokers. Sensitivity refers to
the probability that a smoker will be classified as a smoker.
The specificity and sensitivity of carboxyhemoglobin as a marker
of cigarette smoking has been estimated in epidemiologic studies.
Wald et al. (1981a), sampling afternoon carboxyhemoglobin levels
and using a cutoff-point of 2.0 percent, found specificity to be
99 percent and sensitivity to be 81 percent for cigarette smokers
and 35 percent for cigar and pipe smokers. Cohen and Bartsch
(1980), measuring carboxyhemoglobin in the morning and a similar
cutoff-point, found specificity to be 81 percent and sensitivity
to be 83 percent.
We are also interested in measurements that yield quantitative
information about the amount of a particular smoke component that
is consumed. Carbon monoxide measurements do yield some dose
information, particularly when sampled at the end of a smoking
day.
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It has been shown that for individual smokers carbon monoxide
levels increase proportionately with the number of cigarettes
smoked for the first few hours of smoking (Henningfield et al.
1980). Epidemiologic studies showed significant correlations
between carboxyhemoglobin concentrations and the number of cigar-
ettes smoked per day, with correlations ranging in different
studies from 0.27 to 0.81 (Hawkins et al. 1976; Vogt et al. 1979;
Rickert and Robinson 1981; Jaffe et al. 1981). On the average,
about 25 percent of the variance in carboxyhemoglobin could be
explained by the number of cigarettes smoked per day. The brand
of cigarette or machine yield of carbon monoxide does not signi-
ficantly predict carboxyhemoglobin levels (Rickert and Robinson
1981; Jaffe et al. 1981).
The limitations in using carbon monoxide as a measurement of
tobacco smoke consumption per se are that the time of day and the
length of time since smoking the last cigarette influence carbon
monoxide levels and that there is considerable individual varia-
tion in carbon monoxide absorption and elimination characteris-
tics, depending on smoking habits, disease states, and activity
level.
TABLE 2
Use of carbon monoxide as a measure of smoke consumption
Specificity
Sensitivity
Good
Good at steady state (afternoons)
Short term only
Cost
Limitations
Inexpensive (expired CO)
Time of day
Individual variation in absorption
and elimination (pulmonary
disease; activity)
Measurement of carbon monoxide is straightforward and inexpen-
sive. Because alveolar carbon monoxide pressures are propor-
tional to the concentration of carboxyhemoglobin in blood,
end-expired carbon monoxide tension accurately reflects blood
carboxyhemoglobin (Jarvis et al. 1980). Expired carbon monoxide
can be measured using an instrument (Ecolyzer, Energetics Science,
Inc., Elmsford, NY) that measures the rate of conversion of
carbon monoxide to carbon dioxide as it passes over a catalytic-
ally active electrode. Blood carboxyhemoglobin can be measured
directly and quickly using a differential spectrophotometer
(Co-oximeter, Instrumentation Laboratory, Inc., Lexington, MA).
However, the Co-oximeter is expansive to purchase and requires
considerable maintenance.
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THIOCYANATE
As assessed by smoking machine delivery, approximately 30 to 200
µg of hydrogen cyanide are delivered to the mouth of the smoker
with each cigarette. Hydrogen cyanide is metabolized by the
liver to thiocyanate. In addition to combustion gases, certain
foods, particularly leafy vegetables and some nuts, are sources
of cyanide. Thus, thiocyanate is present in nonsmokers as well
as smokers and may be particularly high in vegetarians. Thio-
cyanate is also present in beer (Bottoms et al. 1982).
TABLE 3
Thiocyanate
Source is metabolism of cyanide
Hydrogen cyanide in stroke
Dietary cyanide
Absorption Respiratory
Ingestion
Elimination Renal
Half-life = 14 days
Measurement Spectrophotometric
Serum vs. saliva
Thiocyanate is distributed in extracellular fluid and is elim-
inated slowly by the kidneys. Due to the slow excretion, the
half-life of thiocyanate is long (about 14 days).
The long half-life of thiocyanate means that there is little
fluctuation in plasma thiocyanate concentrations within a day
or from day to day. Thus, the time of sampling is not critical.
On the other hand, a given level of thiocyanate reflects exposure
to hydrogen cyanide in tobacco smoke over several weeks preceding
the time of the sample. When a smoker stops smoking, it takes an
estimated 3 to 6 weeks for thiocyanate levels to reach that
individual's nonsmoking level.
Because of the presence of cyanide in foods, thiocyanate is not
highly specific for cigarette smoking. There is some overlap in
levels between smokers and nonsmokers. However, on the average,
smokers do have levels two to four times those of nonsmokers
(Cohen and Bartsch 1980; Vogt et al. 1979; Butts et al. 1974).
Levels of 85-100 µmoles/L have been suggested as cutoff concen-
trations for smoking versus nonsmoking. Sensitivity is reason-
ably good in that most smokers have elevated levels: however,
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because of marked variation in levels among nonsmokers, thio-
cyanate concentration may not be a very good quantitative indi-
cator of smoke exposure.
Cohen and Rartsch (1980), using a cutoff-point of 100 µM/L,
reported specificity of 81 percent and sensitivity of 93 percent
for the use of thiocyanate in detecting cigarette smokers. Butz
et al. (1974), using a cutoff-point of 85 µM/L, found 93 percent
and 98 percent specificity and sensitivity, respectively. Thus,
specificity and sensitivity for distinguishing smokers versus
nonsmokers are reasonably good. However, in the smoker who is a
light smoker or who has cut down during smoking cessation treat-
ment, the thiocyanate level approaches levels due to dietary
sources of cyanide, making documentation of smoking status
increasingly more difficult.
Serum or plasma levels of thiocyanate correlate significantly
with the number of cigarettes per day (range of correlation
0.25-0.48) (Cohen and Bartsch 1980; Vogt et al. 1979; Rickert
and Robinson 1981), but not as well as carbon monoxide. Thio-
cyanate levels in smokers do not correlate with machine yields of
hydrogen cyanide. Salivary concentrations of thiocyanate may
also be used as a noninvasive biochemical marker of smoke expo-
sure (Luepker et al. 1981). Concentrations of thiocyanate in
saliva vary as a function of salivary flow rate (Mucklow et al.
1978). Thus, a close correlation between salivary and plasma
thiocyanate concentrations depends on stimulating flow of saliva.
Serum or plasma thiocyanate levels can be measured fairly inex-
pensively using spectrophotometric methods (Butts et al. 1974;
Lundguist et al. 1979).
TABLE 4
Use of thiocyanate as a measure of smoke consumption
Specificity
Sensitivity
Good
Good
Long term
Cost
Limitations
Moderate
Dietary interference
Overlap nonsmokers-light smokers
Not useful to monitor short-term
changes in smoking
In summary, the use of thiocyanate levels as a marker of smoke
consumption has fairly good specificity and sensitivity in study-
ing active smokers, has the advantage of a long half-life such
that the time of sampling is not critical, and is inexpensive to
measure. The limitations are that specificity and sensitivity
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may be inadequate in light smokers or in smokers who have cut
down on their smoking. In addition, the long half-life of thio-
cyanate makes it impossible to use it to assess recent smoking
behavior. Due to other sources of cyanide, thiocyanate is not a
good quantitative indicator of consumption of tobacco smoke.
NICOTINE
As estimated by smoking machine deliveries, between 0.05 and
2.0 mg of nicotine are delivered to the mouth with each cigar-
ette. As is the case for carbon monoxide, nicotine delivery
depends on the characteristics of the cigarette and how the
cigarette is smoked. In studies by Sutton et al. (1982) and
Herning et al. (1983), the increment in blood nicotine concentra-
tion after smoking a single cigarette was correlated poorly with
the smoking machine yield of the cigarette and was more a func-
tion of how the cigarette is smoked.
TABLE 5
Nicotine
Dose 0.1-2.0 mg/cigarette
Varies with cigarette characteristics
and how cigarette is smoked
Absorption Mucous membranes (depends on pH of smoke)
Pulmonary bronchial tree and alveoli
Enteroenteric
Elimination Metabolism primary; renal secondary
4-fold individual variation in metabolic
rate
Renal excretion pH dependent
Half-life = 2 hours
Measurement Gas chromatography
Radioimmunoassay
Blood vs. urine
Unlike carbon monoxide, nicotine is absorbed through mucous mem-
branes in the mouth, through the bronchial tree as well as in the
pulmonary alveoli. The extent of mucosal absorption varies with
the pH of the smoke, such that more nicotine is absorbed from
relatively alkaline (cigar) smoke than from acidic (cigarette)
smoke (Armitage and Turner 1970). Nicotine is distributed
rapidly to body tissues and is rapidly and extensively metabo-
lized by the liver. A relatively small fraction is excreted
unchanged by the kidney. Urinary excretion may vary from 2 to 25
percent of total nicotine elimination in alkaline and acid urine,
respectively (Rosenberg et al. 1980).
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The rate of nicotine metabolism varies considerably, as much as
fourfold among some people (figure 2) (Benowitz et al. 1982a). A
given level of nicotine in the body reflects the balance between
nicotine consumption and elimination rate. Thus, comparing two
persons with the same average blood concentration of nicotine, a
rapid metabolizer may be consuming four times as much nicotine as
a slow metabolizer. To determine daily intake of nicotine
directly, both nicotine blood concentrations and nicotine elimin-
ation rate must be measured. This procedure is feasible for
small-scale studies, and is ongoing in our laboratory. However,
it is not feasible for large-scale studies.
The time course of decline of blood concentrations of nicotine is
multiexponential. Following a single cigarette or an intravenous
injection of nicotine, blood concentrations of nicotine decline
rapidly, with a half-life of 5 to 10 minutes, due to tissue
uptake (figure 3). If concentrations are followed over a longer
period of time or if multiple doses are consumed so that tissue
stores are saturated, a longer elimination half-life of about 2
hours becomes apparent (figure 4). It should be noted that many
earlier reports of nicotine half-lives of 20 to 40 minutes (Isaac
and Rand 1972; Armitage et al. 1975) were based on blood concen-
trations from both distribution and elimination phases and were
not truly measurements of the log-linear decline phase. The
importance of knowing the terminal half-life is that the time
course of accumulation of nicotine during the day and persist-
ence in the body after cessation of regular smoking (such as
overnight) can be predicted.
The optimal way to assess daily exposure to nicotine is to
measure the blood concentrations throughout the smoking day.
This can be carried out in a research ward (Benowitz et al.
1982b) but is not feasible for epidemiologic studies. Pharmaco-
kinetic considerations are useful in planning optimal sampling
of blood for measurement of nicotine concentration to estimate
average exposure levels. As predicted by a 2-hour half-life,
nicotine blood concentrations plateau after 6 to 8 hours of
regular smoking (figure 1). At that point, the fluctuation in
levels between cigarettes is relatively small compared with the
trough levels. This is in contrast to sampling after the first
few cigarettes of the day when there are marked fluctuations in
nicotine levels between cigarettes (figure 5). Afternoon plasma
levels of nicotine have been used in studies of nicotine exposure
while smoking different brands of cigarettes or consuming other
nicotine-containing products (Sutton et al. 1982; Herning et al.
1983; Armitage and Turner 1970; Gritz et al. 1981).
The measurement of blood concentration of nicotine is highly
specific for cigarette smoking unless there is an occupational
exposure to tobacco leaves (Gehlbach et al. 1975). Passive
smoking may elevate blood concentrations of nicotine slightly,
but not to the range seen with most smokers (Russell and Feyera-
bend 1975). Blood concentration of nicotine is a sensitive
measurement of exposure (rather than consumption) to tobacco-
smoked nicotine. Exposure rather than consumption is emphasized
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FIGURE 2
Pharmacokinetics of nicotine in 14 healthy male cigarette
smokers. Pharmacokinetic analysis was performed on plasma con-
centration data collected during and after constant infusion of
nicotine, 1-2 µg base/kg/min, for 60 minutes under conditions of
urinary acidification (pH<5.5). The blood nicotine concentra-
tion-time curve is shown in figure 4. Terminal half-life was
computed from plasma concentration data from 30 to 150 minutes
following the end of nicotine infusion (figure taken from Beno-
witz et al. 1982a). © 1982, American Society for Pharmacology
and Experimental Therapeutics. Reprinted by permission.
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FIGURE 3
PLASMA NICOTINE.
INTRAVENOUS INJECTIONS AND CIGARETTE SMOKING
Plasma nicotine concentrations in a subject given bolus intra-
venous injections of nicotine, 2 µg base/kg, or inhaling from a
commercial cigarette, once every minute for 10 minutes. Nicotine
concentrations rise as or more rapidly while smoking compared
with intravenous dosing. There is a sharp decline in concentra-
tion following the end of the series of nicotine injections or
smoking, due to distribution into body tissues. The terminal
half-life phase (not shown in figure), which reflects rate of
drug elimination, becomes apparent 30-60 minutes following nico-
tine exposure.
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FIGURE 4
NICOTINE
INFUSION
2 µg/kg/min
Plasma nicotine concentrations (± S.E.M.) in five subjects during
and after constant intravenous infusion of nicotine for 30 min-
utes. (Figure taken from Benowitz et al. 1982a.) © 1982,
American Society for Pharmacology and Experimental Therapeutics.
Reprinted by permission.
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FIGURE 5
Mean plasma nicotine concentrations during repetitive intravenous
injections of nicotine with alkaline (pH>7) and acid (pH<5)
urine. Hatched area indicates 10 minute intervals during which
intravenous injections of nicotine, 2 µg base/kg/min, were given.
Data represent mean values for five subjects. There is consider-
able fluctuation in nicotine concentration following and between
series of nicotine injections (or smoking cigarettes) after the
first few exposures. With repetitive dosing, trough levels rise
and eventually (6-8 hours) plateau.
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because of the influence of individual differences in rate of
metabolism of nicotine, as described previously. Measurement of
the blood concentration of nicotine has a major advantage in that
nicotine is the substance for which most people smoke and which
may have direct toxicity. The limitations in the use of blood
concentrations of nicotine are the fluctuation in nicotine con-
centrations between cigarettes and the considerable variation in
nicotine metabolism among individual smokers. In addition, the
method for measuring the low concentrations of nicotine in blood
is more difficult than for other markers.
TABLE 6
Use of nicotine as a measure of smoke consumption
Specificity
Sensitivity
Excellent
Excellent
Short-term only
Cost
Limitations
Expensive
Time of day
Individual variation in
metabolism and renal
excretion
Blood concentrations of nicotine can be measured by gas chroma-
tography (Jacob et al. 1981), radioimmunoassay (Langone et al.
1973), and possibly high performance liquid chromatography.
Sample preparation is problematic in that contamination of
samples with even small amounts of tobacco smoke can substan-
tially elevate the normally low concentrations of nicotine in the
blood. Thus, careful precautions against contamination during
both sample collection and processing for analysis are essential.
Because the concentrations are so low, measurement of nicotine in
blood has been difficult for many laboratories in the past, but
with currently available assays, it is feasible for large scale
epidemiologic studies. Measurement of urinary levels of nicotine
has been suggested as a marker for cigarette consumption (Wilcox
et al. 1979). This may be qualitatively useful, but quantita-
tively it is limited by the fact that there is variation in renal
elimination of nicotine depending on urine pH and flow rate so
that it is difficult to extrapolate from urine to blood concen-
trations of nicotine.
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COTININE
Nicotine is metabolized primarily to cotinine and nicotine-k
oxide. Based on measurements of relative urinary excretion of
cotinine and nicotine-N-oxide and studies of total and renal
elimination of cotinine after intravenous infusion, we estimate
that on the average 86 percent of nicotine is converted to coti-
nine. The individual variation in fractional conversion of nico-
tine to cotinine has not yet been determined.
TABLE 7
Cotinine
Primary metabolite of nicotine
Elimination Metabolism primary, renal
secondary
Half-life = 19 hours
Measurement Gas chromatography
Radioimmunoassay
Cotinine is distributed to body tissues to a much lesser extent
than nicotine. Cotinine is eliminated primarily by metabolism
with 15 to 20 percent excreted in the urine unchanged (Benowitz
et al., submitted for publication). Urinary pH does affect the
renal elimination of cotinine; however, the effect is not as
great as for nicotine. In a small group of subjects given intra-
venous infusions of cotinine, interindividual variation in the
rate of cotinine metabolism was considerably less than variation
in rates of nicotine metabolism. The elimination half-life for
cotinine in 16 subjects who stopped smoking on a research ward
averaged 19.1 hours with a range of 10.9 to 37.0 hours.
Because of the relatively long half-life of cotinine, blood
concentrations of cotinine are relatively stable throughout the
smoking day, reaching a maximum at the end of the day. Because
each cigarette adds relatively little to the overall cotinine
level, sampling time with respect to smoking is not critical. A
mid- or late-day concentration reasonably reflects the average
concentration of cotinine throughout the day.
Using metabolic and pharmacokinetic data, blood concentrations of
cotinine can be used as a measure of daily consumption of nico-
tine. Assuming that nicotine is 86 percent converted to cotinine
and that cotinine clearance is relatively constant among people,
which seems to be the case, it can be computed that a blood
concentration of cotinine of 100 ng/ml represents an average 24
hour consumption of 12 mg nicotine (Benowitz et al., submitted
for publication). Average concentration of cotinine in the
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blood of habitual cigarette smokers is about 300 ng/ml (Langone
and Van Vunakis 1975; Zeidenberg et al. 1977). Thus, I estimate
that the average smoker consumes about 36 mg of nicotine/day.
The range of blood concentrations of cotinine was quite wide, 5
to 900 ng/ml, presumably reflecting a wide variation in nicotine
consumption among self-reported habitual smokers. Concentrations
of cotinine in blood have been used to estimate nicotine consump-
tion in several studies (Zeidenberg et al. 1977; Gritz et al.
1981; Hill and Marquardt 1980; Wald et al. 1981b).
TABLE 8
Use of cotinine as a measure of smoking consumption
Specificity
Sensitivity
Cost
Excellent
Excellent
Intermediate term
Moderate
Limitations ? Individual variation in
elimination rate
The specificity of cotinine as a marker for cigarette smoking is
excellent. I have found no nonsmokers with blood cotinine values
greater than 10 ng/ml. The sensitivity of cotinine also appears
to be excellent and offers the best estimate of daily nicotine
consumption. Because of its long half-life, sampling time is
less critical than for nicotine or carbon monoxide.
Measurement of cotinine is moderately costly. Both radioimmuno-
assay (Langone et al. 1975) and gas chromatographic assays (Jacob
et al. 1981) are readily available. Urinary cotinine ‘may also be
measured as a qualitative indicator of smoking versus nonsmoking
(Wilcox et al. 1979; Matsukura et al. 1979) but, because of indi-
vidual variations in renal clearance, it is not a good quantita-
tive predictor of blood concentration of cotinine.
SUMMARY
In summary, the source, absorption, metabolism, and disposition
kinetics of several compounds that are potential markers of
tobacco smoke consumption have been reviewed. Kinetic considera-
tions have been applied to discuss specificity and sensitivity of
various compounds as markers of cigarette smoking status, useful-
ness as quantitative indicators of tobacco smoke consumption, and
optimal time for sample collection. One cannot, however, escape
the conclusion that selection of a biochemical test must be
linked to the hypothesis being tested. If only smoking versus
nonsmoking is being assessed, then carbon monoxide and/or thio-
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TABLE 9
Comparison of biochemical markers of tobacco smoke consumption
Marker Specificity Sensitivity Limitations cost Advantages
Carbon monoxide Good Good short term Time of sampling Inexpensive Direct toxin
Variable absorption Noninvasive
and elimination (Expired CO)
Thiocyanate Good Good long term Dietary interference Moderate Noninvasive
Qualitative measure (Saliva)
Nicotine Excellent Excellent short Time of sampling Expensive Direct measurement
term Variable elimination of reinforcer or
rate toxin exposure
Cotinine Excellent Excellent inter- ? Variable elimination Moderate Measurement of
mediate term rate nicotine
consumption
cyanate are inexpensive measurements that provide adequate infor-
mation. If self-administration of nicotine or toxic effects
potentially related to nicotine exposure are being studied, then
measurements of nicotine exposure and consumption are required.
Measurement of blood concentration of nicotine per se is neces-
sary to document nicotine exposure: blood concentration of coti-
nine may be a better measure of daily nicotine consumption. To
study potentially carcinogenic effects of tobacco smoke, specific
measurements of carcinogen consumption must be developed and
validated.
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Measurement Issues in Cigarette
Smoking Research: Basic Behavioral
and Physiological Effects and Patterns of
Nicotine Self-Administration
Jack E. Henningfield, Ph.D.
INTRODUCTION
Measurement issues in cigarette smoking research encompass a
heterogeneous body of research questions and strategies.
Included are investigations into the types and amounts of
tobacco smoke constituents delivered by cigarettes, topographic-
al analysis of puffing behavior, epidemiological studies of
smoking behavior, health-related consequences of smoking, and
investigations of cigarette smoking behavior. The primary focus
of the present paper will be on studies of the dependence
process in which drug self-administration strategies were used.
Some of the underlying principles of such strategies are
described below.
The conceptualization of drug abuse as an instance of drug
self-administration, that may be studied in the laboratory, is
one of the essential tenets of behavioral pharmacology (Thompson
and Schuster 1968; Poling and Henningfield 1982). These
strategies have now been fruitfully applied to the study of
cigarette smoking (Gritz 1980; Griffiths and Henningfield
1982). The power of such strategies lies in their potential to
reproduce, under rigorous laboratory conditions, the essential
elements of the phenomena of drug-seeking and drug-taking
behavior. A given instance of drug self-administration involves
numerous elements which are of behavioral, physiologic, pharma-
cologic, social, and environmental nature. The drug self-admin-
istration paradigm permits the systematic manipulation of such
variables so that the relative contribution of each can be
assessed (cf. Griffiths, Bigelow, and Henningfield 1980).
The focus of drug self-administration studies is on operant
behavior, or chains of behavior that are relatively free to
occur, not to occur, or to occur in altered form, e.g., the
procurement and smoking of cigarettes. The strength of operant
behavior is assessed by its rate or probability of occurrence.
When the maintenance of such a chain of behavior is dependent
upon the delivery of a given stimulus, that stimulus is said to
27
be functioning as a positive reinforcer, regardless of the
underlying reasons for which the stimulus holds that property,
e.g., tobacco smoke inhaled from a cigarette is the reinforcer
for the operant behavior entailed by cigarette smoking. Ante-
cedent stimuli which signal conditions under which an instance
of operant behavior is likely to be reinforced are termed
discriminative stimuli; their power in setting the occasion for
operant behavior to occur (i.e., increasing the probability of
occurrence of the behavior) is dependent upon prior instances of
the behavior being reinforced in their presence. The prior
conditioning histories of such stimuli may be specific to the
behavioral sequence at hand and may function additively, e.g.,
the smell of tobacco smoke and the onset of early nicotine
withdrawal symptoms may each tend to set the occasion for
smoking, while the contiguous occurrence of both sets of stimuli
may produce an extremely high probability situation in which
smoking may occur. The prior histories may also be nonspecific
to the behavior at hand but equally effective at setting the
occasion for the behavior to occur. Modeling the behavior of
peers, obeying the instructional demands of perceived superiors
or role models, and adhering to social and familial norms are
generally conditioned from birth. It should come as no surprise
when these kinds of discriminative stimuli function with such
efficacy, e.g., when adolescents learn to smoke together, when
advertising strategies use the ‘Brand X Man’ or the ‘Brand Y
Woman,” and when it is discovered that smokers are not randomly
distributed across the population but, rather, tend to be
clustered into small social units of smokers and nonsmokers
(e.g. coworkers, friends, family).
In the studies described in the present paper, two general
self-administration strategies are utilized: a cigarette
smoking paradigm, and an intravenous nicotine self-adminis-
tration paradigm. Data collected using these paradigms provide
an experimental basis for assessing the role of the multiple
factors involved in cigarette smoking. Some of these factors
are described below.
SOME PROBLEMS OF MEASUREMENT IN TOBACCO RESEARCH
Fundamental to any self-administration study is to provide a
standard unit of the substance to be delivered, as well as to
quantify intake. Typically, in drug self-administration
studies, a predetermined dose of drug (e.g., mg per delivery or
mg per body weight per delivery) is delivered, and the total
drug intake over time is measured (e.g., mg per hour). In
studies of cigarette smoking, however, this fundamental con-
dition is confounded by the factors described in Figure 1. As
shown in the figure the nature and quantity of constituents in
any given puff is a function of multiple factors including
cigarette constitution, puff topography, inhalation character-
istics, and so forth.
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PRODUCTION AND FATE OF CIGARETTE SMOKE CONSTITUENTS
Figure 1. This illustration shows the complex sequence
of events whereby a tobacco cigarette, comprised of a
variety of constituents, is burned, thus yielding new
constituents. The mainstream smoke is filtered and
diluted as it passes through the cigarette and into the
mouth. Smoke from the tip of the cigarette (side
stream smoke) may be inhaled directly and thus be
higher in concentration of certain constituents.
Finally, a variable amount of the produced and puffed
smoke is inhaled into the lungs where absorption will
depend on a variety of factors.
Given the complexity of the physical and behavioral processes
involved in the production and eventual intake of tobacco smoke
constituents, it would seem that dose assessment could only
result from a profile of the various measurable parameters.
These include (1) puffing parameters (e.g., rate and volume),
(2) inhalation parameters (e.g., rate and volume), (3)
physiologic intake parameters (e.g., CO level and plasma nic-
otine), and (4) subjective effects parameters (e.g., self-repor-
ted strength of cigarette). All of these factors may bear
complex and dependent relationships to one another, and may be
most meaningfully addressed as elements of a profile.
Multiple variable measurement, yielding a profile of effects,
provides one solution to the issues raised above. Figure 2
shows the profile of effects determined in a study of the
effects of d-amphetamine on cigarette smoking in normal volun-
teers (Henningfield and Griffiths 1981). As shown in the fig-
ure, a variety of measures showed dose-related changes. The
collection of several variables permits a more meaningful analy-
sis of the results. For instance, the CO measure confirmed
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that subjects were not simply puffing more, but were actually
inhaling more smoke. Another approach to addressing the
problem in measurement concerning delivered and obtained doses
is to present known quantities of a pure form of the substance
under study, for instance, to deliver intravenous doses of
nicotine. However, such an approach assumes that intravenous
nicotine is functionally equivalent to nicotine delivered via
inhaled tobacco smoke.
Figure 2. For each dependent variable, the
overall man value (n = 40, 8 subjects x 5
sessions) is shown as a function of d-amphetamine
dose. The dashed line indicates the 95%
confidence interval for placebo. The y axis
shows the units of measurement appropriate to the
dependent variables indicated in individual
graphs. (© The c. v. Mosby Company. From
Clinical Pharmacology and Therapeutics, Vol. 30,
No. 4, 1981. Reprinted with permission.)
EQUIVALENCE OF IV NICOTINE TO TOBACCO SMOKE
Before studies of nicotine self-administration were conducted,
some of the effects of nicotine given intravenously or in the
form of research cigarette smoke were compared using biological
assay procedures (cf. Finney 1962). Subjects were given a range
of doses of nicotine, intravenously and in the form of inhaled
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tobacco smoke. Drug dosing was double-blind, following an
initial "dose run-up" study done with each subject to verify the
safety of the doses. Before, during, and after drug adminis-
tration, a variety of subjective and physiologic variables were
measured. The research staff also made behavioral observations
about the subjects (the procedures used and the results obtained
have been described in greater detail elsewhere: Henningfield et
al. 1983a).
The main findings of this study were that nicotine produced
similar profiles of effects given via the intravenous route or
in the form of inhaled tobacco smoke: Dose-related increases in
scores on scales of drug dose strength, drug liking, and euphor-
ia (MEG scale of the Addiction Research Center Inventory),
decreases in desire to smoke, increased heart rate and blood
pressure (the high iv dose produced an initial bradycardia), and
decreased skin temperature. Peak subjective effects occurred
within the first minute of administration of nicotine (or
completion of the cigarette) and declined to negligible levels
within a few minutes. There were some differences between iv
and inhaled nicotine: Inhaled nicotine was more effective at
decreasing the desire to Smoke, and intravenous nicotine was
identified as a euphoriant producing a "rush" similar to that
produced by cocaine or morphine (though of much shorter
action). A subsequent study (Henningfield et al. 1983b) showed
that nicotine produced early effects on other physiologic
measures that corresponded with the changes in heart rate and
subjective response observed in the former study. For instance,
pupil diameter first increased, then decreased, and returned to
saline levels within a few minutes of injection. The more
recent study also showed that mecamylamine pretreatment blocked
physiologic responses to nicotine and attenuated subjective
effects of nicotine (mecamylamine is a ganglionic blocker used
as an antihypertensive medication).
This series of studies confirmed findings from earlier studies
that nicotine produces many of the effects of cigarette smoking
(cf. review by Gritz 1980), and the findings showed that
nicotine’s profile would contribute to its role as a pharmaco-
logic mediator of compulsive cigarette smoking, i.e., by
reinforcing the behavior of tobacco smoke self-administration.
Further, these findings support the validity of using intra-
venous nicotine self-administration as a model to study pharma-
cologic aspects of cigarette smoking.
SELF-ADMINISTRATION OF INTRAVENOUS NICOTINE BY HUMAN SUBJECTS
The findings of the study summarized above were consistent with
those of other investigators (cf. reviews by Gritz, 1980;
Griffiths and Henningfield, 1982) suggesting that nicotine is
the critical pharmacologic mediator of the behavior of cigarette
smoking. To further study the role of nicotine in the
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dependence process of cigarette smoking, a series of studies was
conducted in which intravenous nicotine was available in place
of cigarettes. Some of the issues of scientific importance that
can be addressed by the self-administration approach include the
following: (1) Can nicotine, in the absence of the vast array
of stimuli involved in cigarette smoking, serve as a positive
reinforcer and thereby maintain self-administration? (2) How
does nicotine compare to other psychoactive drugs which have
been studied in self-administration paradigms? (3) How do pat-
terns of nicotine self-administration compare to patterns main-
tained by cigarette smoke? (4) How is the behavior of nicotine
self-administration affected by pharmacologic manipulations?
General Methods
Subjects resided on the research ward for the 6- to 12- week
duration of studies. Experimental sessions were 3 hours and
were scheduled 1 to 3 days apart. Prior to a session, the
subject was catheterized in a forearm vein using a standard
intravenous infusion set. Automatically activated syringe pumps
were used for injections. Dose volume and infusion duration
were 1 ml and 10 sec, respectively. During sessions the sub-
jects sat in a reclining chair in isolation and had access to a
radio and magazines. Cigarette smoking was not permitted for 1
hour prior to or during sessions.
Before and after each session, basic vital signs were collected
by the research staff. Subjects then also completed three
questionnaires: (1) A short form (40 items) of the Addiction
Research Center Inventory (ARCI) which contains empirically
derived scales sensitive to the effects of several classes of
psychoactive drugs. (2) The Single Dose Questionnaire (SDQ)
which contains a scale of drug liking and a drug identification
list with the street names of 10 common psychoactive drugs. (3)
A newly developed form with rating scales of drug dose strength,
and desire to smoke a cigarette. Additionally, 1 minute after
each injection the liked and disliked effects of the injection
were rated by the subject on 100 nun line visual analogue
scales. An operant test panel with two levers and attendant
stimulus lights were located near the subject’s reclining chair.
Prior to the study, the safety of the nicotine dose levels was
verified by injecting the subjects with each of the possible
doses at 1 hour intervals in an ascending sequence. They were
told that only doses from among this sequence, or placebo, would
be available during the self-administration study, but they were
given no information regarding the specific nicotine dose
available during any session nor the schedule of its availa-
bility. In some studies, sessions were preceded by oral admin-
istration of mecamylamine. Subjects were told that any lever
pressing or drug taking was voluntary; they were not asked OK
encouraged to take injections.
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Studies were conducted following review and approval of the
study plan by the Institutional Review Board. To further ensure
the safety of subjects, (a) a one-minute time-out followed each
injection, (b) there was a programmed maximum limit on the
number of injections available during successive thirty minute
intervals, (c) a research nurse observed the subject and the
subject’s continuous electrocardiogram display and was free to
abort the session at his or her discretion, and (d) the subject
was free to abort the session at any time.
RESULTS
In the initial study of nicotine self-administration, subjects
were presented with one dose of nicotine or saline during
sessions; ten responses on one lever produced drug, while
responding on the other lever had no programmed consequence
(Henningfield et al. 1983c). Figure 3 shows patterns of nic-
otine injections taken under such conditions. All of the six
subjects tested self-administered both nicotine and saline;
however, nicotine injections occurred in regular patterns,
whereas saline injections occurred with wide variablility in
pattern and frequency, both within and across subjects.
Patterns of nicotine self-administration were similar to those
of humans smoking cigarettes and to animals self-administering
psychomotor stimulants (Griffiths et al. 1980). In some of the
subjects, comparison of nicotine- to saline-maintained lever
pressing suggested that nicotine was serving as a positive
reinforcer, while in other subjects it appeared that nicotine
was serving as an aversive stimulus relative to saline. Unlike
the study of single dose nicotine administration in which desire
to smoke was decreased in dose-related fashion, desire to smoke
was not reliably decreased in this study. However, the behavior
of smoking (cigarettes smoked and puffs taken) was decreased
following sessions in which nicotine was self-administered as
compared to sessions in which saline was available.
A subsequent study examined the effects of systematic within-
subject manipulations of nicotine dose in human and squirrel
monkey subjects when ten lever presses were required per
intravenous nicotine injection (Goldberg and Henningfield
1983). With the human subjects nicotine and saline were
presented concurrently, while with the animal subjects saline
and nicotine were presented across sessions. The results of the
study were similar in both species.
In the Goldberg and Henningfield study, all subjects self-admin-
istered both nicotine and saline. Nicotine injections exceeded
saline injections in three of the four humans and three of the
four monkeys tested, indicating that nicotine was serving as a
positive reinforcer for these subjects. The highest dose of
nicotine decreased injection rates, though amount of nicotine
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I.V. NICOTINE INJECTIONS
Figure 3. Intravenous nicotine self-administra-
tion by cigarette smokers. The vertical marks
indicate injections obtained by each subject
during a 3-hr session. For subjects BE, KO and
LA, the data shown are those from a
representative session at the 1.5 mg per
injection dose: for subjects SK, KU and PE, the
data are from the only session in which the 1.5
mg dose was available. The actual unit dose for
each subject , expressed as ug nicotine per kg
body weight, is indicated on the right side of
each record.
obtained per session was relatively unchanged. With the human
subjects, as injection dose increased from 0.75 to 1.5 mg, there
was little change in number of injections taken per 3 hour
session. However, when dose was increased to 3.0 mg, number of
injections per session decreased. This is interesting since
studies of the effects of nicotine yield in cigarettes on
cigarette smoking behavior have shown little effect on rate of
cigarette consumption except when nicotine yield of the
cigarettes was in excess of 2 mg per cigarette (Griffiths et al.
1980).
Self-administration studies in animals and humans with opioid
agonists (e.g., morphine) have shown that pretreatment with
antagonist drugs (e.g., naltrexone) decreases the reinforcing
efficacy of the opioid, relative to placebo (Griffiths et al.
1980). These results suggest that nicotine self-administration
might also be reduced by pretreatment with an antagonist.
Studies of intravenous nicotine self-administration by animals
have shown that the reinforcing efficacy of nicotine is reduced
by pretreatment of the animals with mecamylamine (e.g., Spealman
and Goldberg 1982).
34
To assess the effects of mecamylamine on nicotine self-admin-
istration behavior, a subject was pretreated with mecamylamine
or placebo, 1 hour before 3-hour sessions. Nicotine, in 3 mg
doses (IV) and saline were concurrently available by pressing
either of two levers (the nicotine and saline levers were
alternated each day, and the subject was told that pressing on
either lever could produce any of a previously given range of
doses of nicotine or placebo).
MECAMYLAMINE (mg)
Figure 4. Mean values (n = 3 sessions) and
S.E.M. of dependent variables when the available
nicotine dose was constant across sessions (3.0
mg) and the presession mecamylamine dose was
varied from 0 to 10 mg. The shaded bars indicate
the mean visual line analogue scores obtained 1
minute following each of the first three injec-
tions of a session. The striped bars indicate
the percent of total number of injections during
a session that were nicotine injections.
Figure 4 shows that mecamylamine pretreatment produced a dose-
related blockade of the subjectively liked effects and of the
reinforcing effects of nicotine. Liking scores on a 100 mm
visual line analogue scale were decreased by nicotine (0 mm = no
effect and 100 mm = very strong positive effect). The prefer-
ence for nicotine, as compared to saline, was decreased by
mecamylamine administration.
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IMPLICATIONS
These studies suggest that measurement issues can be surmounted
by systematically applying the methods of behavioral pharm-
acology and biological assay procedures. Use of multiple
measures helped to resolve issues arising from any single
measure (e.g., the relationship between nicotine’s effects on
desire to smoke versus the behavior of smoking). Studies with
intravenous nicotine showed that nicotine, in its own right, is
an abusable drug, and that nicotine produces physiologic,
subjective, and behavioral effects which are generally similar
whether nicotine is delivered intravenously or via tobacco smoke
inhalation. Subjective effects are qualitatively similar to
those produced by abused drugs such as cocaine. Certain effects
onset within seconds and offset within minutes. Mecamylamine
selectively attenuates interoceptive effects, though higher
doses block physiologic responses to nicotine. The fundamental
implication of the self-administration study is that nicotine
was voluntarily taken in place of cigarettes, in the absence of
the vast array of stimuli (social, taste, etc.) normally concom-
mitant to nicotine taking by cigarette smoking, thereby indi-
cating that nicotine may function as a positive reinforcer.
Taken together, these results show that cigarette smoking is
appropriately categorized as an instance of drug dependence in
which nicotine is the key pharmacologic mediator of the
behavior. A caveat, applicable to all forms of drug dependence,
is that the pharmacologic mediator is only one of many compon-
ents involved in the acquisition, maintenance, and elimination
of the dependence proccess. However, knowlege concerning the
role of a pharmacologic mediator provides a rational basis for
pharmacologic aids for the treatment of the behavior. For
instance, a nicotine substitution treatment (e.g., nicotine
containing chewing gum) or a nicotine blocking treatment (e.g.,
mecamylamine) may be of use.
The emerging conceptualization of cigarette smoking is that
cigarette smoking may be regarded as an instance of voluntary toxin
self-administration. Unlike other forms of toxin self-admin-
istration, however, in which knowledge of the toxic effects of
the substance (e.g., dioxin in drinking water, or asbestos in
air) is frequently sufficient for the behavior to change, in the
case of cigarette smoking, the toxins (specifically, tar, CO and
particulate matter) are accompanied by a psychoactive compound
that reinforces the behavior of self-administration. It is
clear that any serious attempt to reduce the disease and
suffering caused by cigarette smoking will need to consider
these issues (U. S. Department of Health and Human Services,
1983).
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Analysis of Reinforcement
by Varying Smoke Com-
ponent Concentrations
Jed E. Rose, Ph.D.
Since nicotine is thought to be one of the principal reinforcing
constituents in tobacco, a logical way to classify smokers may be
to distinguish those who are dependent on nicotine from those who
smoke for other reasons, e.g., other components of tobacco,
sensory/motor aspects of the habit, or social reasons (Russell et
al. 1974). The role of nicotine in cigarette smoking has been
studied by examining smokers' reactions to cigarettes of different
nicotine deliveries or to nicotine preload. By observing
compensatory charges in smoking behavior in response to variable
nicotine delivery (titration) it was hoped that the reinforcing
role of nicotine would be highlighted. The empirical findings have
typically demonstrated statistically significant, but often slight,
compensatory changes in response to varying nicotine yields (Ashton
and Stepney 1982; Gritz 1980).
The methodology about to be described was designed to study the
reinforcing actions of nicotine in smokers in a way that would
overcome two conceptual problem inherent in most nicotine
titration studies. The first problem is that if nicotine is a
reinforcer for smoking, smokers would not be expected to like
low-nicotine cigarettes, and in that case it would not be
reasonable to expect them to smoke for example, 10 times more of a
0.1 mg nicotine cigarette than of a 1.0 mg nicotine cigarette
(which would be required for complete titration of nicotine
intake).
The second problem is that even if titration does occur, it would
be consistent with the view that nicotine is aversive rather than
reinforcing and that smokers are obtaining other reinforcers from
the cigarette (Russell 1979). Although the titration paradigm may
be useful from a practical standpoint for investigating smokers'
responses to altered yield cigarettes, it is not an appropriate
methodology for the study of nicotine's reinforcing value.
METHOD
The new methodology to be described here explores variations in
nicotine preference In which the concentration of nicotine in each
puff of smoke is under the subject's control. In this choice
procedure, subjects utilize a smoke-mixing apparatus to adjust the
nicotine concentration in cigarette smoke on a puff-by-puff basis
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and select an optimal nicotine delivery. The rewarding and/or
aversive properties of nicotine at a specific time can be inferred
by the nicotine level chosen.
The smoke-mixing device (figure 1)1 consists of a two-barreled,
glass cigarette holder, constructed from a three-way stopcock, that
blends smoke from two, sources: a high- and a low-nicotine
cigarette, roughly equivalent in other respects (e.g., tar
delivery, carbon monoxide). For this purpose, we have employed the
University of Kentucky Reference cigarettes: 2A1, 0.45 mg
nicotine, 36.4 mg tar; 2R1, 2.45 mg nicotine, 35.8 mg tar. As in
blending hot and cold water with a faucet, subjects may turn a knob
and vary the ratio of smoke drawn from the two cigarettes and,
hence, the nicotine concentration of the smoke inhaled. The mixing
of smoke takes place within the modified Teflon stopcock, also
shown in figure 1. The center core of the stopcock was first
drilled out, and then three slits were cut to allow the inside to
communicate with the exterior. One of these slits, the largest
(approximately 3 mm wide), connects to the mouthpiece and allows
smoke to travel unimpeded into the smoker's mouth. The other two
slits, located on the opposite side of the stopcock, are much
narrower (approximately 1.2 mm wide). These two smaller slits are
offset with respect to each other, so) that when one is perfectly
aligned with one channel of the cigarette holder, the other is not,
and vice versa. Intermediate rotations of the stopcock cause
partial aligment of each slit with the corresponding channel in
varying degrees. At a given setting, same smoke is drawn through
each side of the mixer. The precise ratio depends on the alignment
of the slits, which is controlled in turn by the adjuster (vernier)
knob operated by the subject. The overall draw resistance
present& by both slits is negligible compared to that of a
cigarette.
The flow of smoke through each side of the holder is measured by
differential pressure transducers (Statham Model PM6TC±2.5-350),
which sense the pressure difference across the restriction tuba in
each barrel. The diameter of this tube (1.6 mm) is sufficient to
prevent accumulation of smoke residue and presents a small, fixed
draw resistance. The use of differential pressure. measurements
across a constant resistance is necessary so that variations in the
length of the cigarette as it burns do not affect the relationship
between flow and pressure measured by the transducer. This system
is similar to those used previously in studies of smoking
topography (Creighton et al. 1978; Rawbone et al. 1978). The
output from the transducers leads to a polygraph to be recorded,
and measuring the height of the puff profile on each channel yields
the flow through that side. Two additional polygraph channels
record the volume of smoke taken in through each channel, after
intermediate circuitry has linearized and integrated the signals
from the pressure transducers. Calibration records were produced
by independent determination of flows using a vacuum pump and
Gilmont spherical float flow meters. The estimate of nicotine
delivery (Nic) of the smoke mixture is computed as follows:
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SMOKE MIXING DEVICE
Figure 1
Smoke-mixing device used to assess smokers’ nicotine preference. The knob controls the positions of mixing
slits which blend high and low nicotine smoke to achieve intermediate nicotine deliveries.
Tar delivery is held constant with the research cigarettes employed. The mixture setting chosen with
each puff is measured with pressure transducers that monitor the flow of smoke through each barrel
of the mixer.
Copyright 1982 Psychonomic Society, Inc.
Reprinted by permission of the author.
Nic (mixture) = Volume (Side 1)Nic 1 + Volume (Side 2)Nic 2
Volume (Side 1) + Volume (Side 2)
Nic 1 and Nic 2 are the nicotine deliveries for the two types of
cigarettes employed.
There are two main sources of error to be considered in this
measurement. The first is random variations in nicotine delivery
between puffs from cigarettes of a given type. This error includes
variations in nicotine concentration accompanying changes in the
rate of puffing or volume (Creighton and Lewis 1978). The
magnitude of this error is probably Less than ±10% in the range of
puff parameters commonly encountered; however, observed puff
volumes and interpuff intervals could be used in a retrospective
analysis to improve the estimates of per-puff nicotine deliveries.
The second source of error is the systematic increase in the
concentration of smoke products across puffs from a single
cigarette due to the rod filtration effect (Russell et al. 1979;
Wiley and Wickham 1974: Young et al. 1991). This factor can be
corrected, for it is known precisely how nicotine deliveries vary
across the length of the particular cigarettes employed, and it can
be minimized by restricting smoking to the distal halves of the
cigarettes used. The burn rates of the two types of University of
Kentucky research cigarettes are very similar over a wide range of
mixture settings, so that the lengths and relative contributions of
each cigarette to total nicotine delivery remain nearly constant
across the length of the cigarettes.
A simpler measure of nicotine preference may also be employed: the
relative ratio of smoke drawn through the high nicotine side. This
latter measure more clearly reflects the behavior of the subject
(in adjusting the knob position) and is less sensitive to
inaccuracies in determining absolute nicotine deliveries per puff.
Positively reinforcing aspects of nicotine would be unambiguously
demonstrated by the choice of a mixture delivering more than 50%
smoke from the high nicotine side, and, conversely, an aversion to
nicotine would be clearly evidenced by a selection of the lowest
nicotine delivery. Selection of a 50-50 mixture would indicate
either indifference to nicotine or a positive preference for that
intermediate nicotine level. Selection of mixtures delivering
between 0 and 50% from the high nicotine side are similarly
ambiguous in that they would be consistent either with a mild
aversion to nicotine or simply a preference for a positiveliy
reinforcing, but lower concentration, of that substance.
Inasmuch as smoking abstinence has been shown to be a potent
variable influencing subsequent smoking (Kumar et al. 1977;
Henningfield and Griffiths 1973), our first goal in the behavioral
application of the smoke mixer was to measure variations in
nicotine preference resulting from smoking abstinence and
satiation. In analogy to the work of Gabanac (1971), who showed
that food-deprived subjects preferred more concentrated sugar
solutions than satiated subjects, it was predicted that if
cigarette deprivation produced a nicotine "hunger," subsequent
preference for nicotine should likewise increase.
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Subjects
Twenty smokers, who regularly consumed at least a pack a day, and
whose customary brand of cigarette delivered (by FTC method) over
0.5 mg, were recruited for the study. Subjects included 12 males
and 3 females, with an average age of 38 years.
Procedure
Subjects' nicotine preference was assessed under two, conditions:
Deprivation, in which subjects abstained from smoking for
approximately 2 hours (1 hour before entering the laboratory and an
additional 50 minutes after arriving): and Satiation, in which
subjects smoked two cigarettes of their own brand in the 20 minutes
immediately prior to the nicotine preference test.
During the nicotine preference test, subjects were instructed
simply to find their preferred nicotine concentration, using the
mixing device to blend smoke with each puff from the high and low
nicotine research cigarettes. They were free to use any cues for
finding their optimal nicotine mixture, including the immediate
sensory impact of nicotine (Cain 1980), or the pharmacologic
effects which occur within seconds of inhalation (Russell and
Feyerabend 1979). To the extent subjects desired the higher
nicotine smoke, they could adjust the mixture to as high as 2.45
mg. (Mean nicotine delivery of subjects' habitual brands was 1.60
mg.) For half of the subjects, the high-nicotine cigarette was
placed in the left barrel of the mixer, and for the other half the
positions of the high- and low-nicotine cigarettes were reversed.
A replication of each condition was presented (an a different day),
and since the results from the days within a condition did not
differ, the data were averaged across replications. Two behavioral
measures of smoking were compared between Deprivation and Satiation
conditions: 1) average nicotine preference (averaged across all
puffs taken in the preference test); and 2) number of puffs taken
during the test. Additionally, after each puff subjects used two
ten-pint scales to rate the perceived "strength" and
"desirability" of the smoke.
RESULTS AND DISCUSSION
Figure 2 depicts the results, which show subjects' preference for
significantly higher nicotine concentrations in the Deprivation
condition than in Satiation (t=2.23, p<.04). Further, subjects who
selected consistently higher nicotine levels in Deprivation than
Station in both replications (n=9), chose a mixture in
Deprivation that was not only greater than the low-nicotine extreme
but also significantly higher than the 50-50 indifference point
(t=2.42, p<.05). This constitutes direct evidence confirming
nicotine's role as a desired ingredient in cigarette smoke.
Ingesting high-nicotine smoke was more reinforcing after A period
of cigarette deprivation, when nicotine levels ware presumably low.
Smoking abstinence indeed seems to evoke a hunger for nicotine in
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Figure 2
Mean nicotine preference and number of puffs taken during test smoking period after two hours'
smoking abstinence (Deprivation) and after smoking two cigarettes (Satiation).
Significant elevations in both smoking parameters occurred after cigarette deprivation.
at least some smokers. For the same subjects, the level of
nicotine selected during Satiation was marginally lower than the
indifference point (t=2.22, p=.06), suggesting that nicotine
aversion may have influenced preference in Satiation (see figure 3).
The assessment of nicotine's aversive qualities depends in part
upon whether the criterion for aversion is the choice of a mixture
below the indifference point or selection of the lowest nicotine
level possible. Subjects also took significantly more puffs after
a period of cigarette deprivation than when satiated (t=2.73,
p<.02). Subjects thus increased nicotine intake after smoking
abstinence in two ways: taking more puffs as well as increasing the
nicotine {mixture of each puff. The increase in puffing was, of
course, not a specific measure of nicotine-seeking (unlike the
mixture adjusment) and may have reflected deprivation for
non-nicotine factors in the smoking habit, such as oral or
manipulative reinforcement.
In the Satiation condition suppression of smoking was not complete.
This may have been due to the fact that the two cigarettes
presented in Satiation were insufficient to reverse the effects of
almost 2 hours' Deprivation, during which many subjects would have
smoked as many as three or four cigarettes. Alternatively, there
may be an extremely rapid recovery from the satiating effects of
cigarette smoking, storming from the very short distributional half
life of nicotine (Benowitz et al. 1982).
In order to identify characteristics of smokers who were more
responsive to the Deprivation manipulation, additional statistical
analyses were conducted. The magnitude of increase in nicotine
preference with Deprivation was found to be positively correlated
(r=.61, p<.O1) with the subject's age. In contrast, subjects whose
puffing behavior was most affected by the experimental maniplation
tended to report smoking most in social situations (r=.63, p<.01).
The fact that puffing and nicotine preference were correlated with
different subject characteristics suggests that these two factors
may represent different types of reinforcement gained from smoking.
The subjective judgments of strength and desirability also differed
between experimental conditions. Puffs were rated as significantly
Less strong (t=2.25, p<.04) and more desirable (t=2.38, p<.03)
following Deprivation. Desirability ratings from each subject did
not correlate with nicotine delivery (t=0 and .05 for Deprivation
and Satiation, respectively, p>.5), suggesting that many other
factors affect the subjective enjoyment of smoking, or,
alternatively, that each subject's ratings varied nonlinearly with
nicotine delivery. Goldfarb et al. (1976) and Pose (1983) also
reported the absence of a correlation between satisfaction ratings
and nicotine delivery, whereas strength ratings were positively
correlated with nicotine. In the present study, subjects generally
displayed a positive correlation between nicotine content of each
puff and perceived strength (t=4.36 and 6.23 for Deprivation and
Satiation, respectively, p<.001). me fact that subjects rated
puffs as weaker in Deprivation, even though the nicotine levels
chosen were higher than in Satiation, suggests that smoking
deprivation induces a substantial downward shift in the sensitivity
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Figure 3
Nicotine preference of subjects who consistently chose higher nicotine levels after cigarette deprivation
(responders) and those who were unaffected by this manipulation (nonresponders). After deprivation,
responders selected smoke mixtures containing significantly more than SO% high nicotine smoke,
which demonstrates the positively reinforcing qualities of nicotine in this condition.
to nicotine. The slopes of regression lines relating perceived
strength and nicotine content did not differ across conditions
(t=.98, p>.3), so the shift in strength ratings represents a
uniform bias rather than a change in discriminability per se.
Perhaps this shift reflects a comparison between the perceived
qualities of the smoke and the desired level of nicotine as
determined by internal cues. Also involved may be the
responsiveness of receptors mediating the common chemical sense,
located in the pharynx and sublaryngeal regions (Cain 1980), or the
sensitivity of CNS receptors for nicotine (Abood et al. 1979). The
relative importance of central versus peripheral stimulation in
discriminating nicotine's reinforcing effects has not as yet been
firmly established. Further studies which identify the factors
affecting nicotine preference and satiation should significantly
clarify the psychopharmologic basis of cigarette smoking.
Although primarily designed to study nicotine preference, the smoke
mixing methodology can be applied to the investigation of other
factors important in smoking reinforcement. For example, "tar" has
been suggested to play an important role in modulating the sensory
and pharmacologic effects of inhaled nicotine, and conceivably
contains additional constituents important in their own right
(Goldfarb et al. 1975). By placing in the smoke mixer cigarettes
of equal nicotine delivery but high and low in tar delivery,
preference for tar concentration may be measured. Technical
refinements will allow the construction of cigarettes with
alterations in the delivery of more specific ingredients.
Preference for any constituent of tobacco smoke may thus be
explored with the present methodology, if cigarettes are available
with high and low yields for that particular component.
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FOOTNOTE
1. This paragraph, the following two paragraphs which describe the
smoke-mixing device, and figure 1 are reprinted from Rose, J.E.;
Lafer, R.L.; and Jarvik, M.E. A smoke-mixing device for measuring
nicotine preference. Behavior Research Methods & Instrumentation
14(6), 501-503, 1982. Copyright 1982 Psychonomic Society, Inc.
They are reprinted by permission.
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Physical Indicators of Actual Tar
and Nicotine Yields of Cigarettes
Lynn T. Kozlowski, Ph.D.
By the late 1960s, cigarette tar was becoming officially dangerous to the
health of smokers (e.g., USPHS 1964). Those who refused to stop
smoking were encouraged to smoke lower tar and nicotine cigarettes. In
1967, the Federal Trade Commission (FTC) established a laboratory to
conduct standardized assays of the tar and nicotine yields of cigarettes.
This standard smoking-machine procedure provided the yardstick by
which all cigarettes were to be measured. Lower tar cigarettes, by
definition, deliver lower tar when smoked in the standard fashion of one
2 second long, 35 ml puff each minute until a fixed butt length IS
reached. Except for small differences in rules for butt length, this
machine procedure is the internationally standard way to smoke
cigarettes in the analytical laboratory (Coresta 1969; ISO 1977).
Whenever and wherever (world-wide), one sees official tar and nicotine
yields, whether in a United States Surgeon General’s Report or on a
billboard, one can assume that the brand in question has undergone this
exact smoking regimen.
THE CRADLE OF THE STANDARDIZED SMOKING MACHINE TEST
Interestingly, the origin of the 2 sec, 35 ml puff/mm regimen IS generally
not known. Although my research has explored limitations of standard
smoking-machine assays (Kozlowski et al. 1980b; Kozlowski 1981a;
Kozlowski 1981b; Kozlowski et al. 1982b), I had not tried to trace the
origins of the puffing regimen. It has been assumed that average
human smoking behavior somehow provided the basis for the procedure.
Further, it has been assumed that the standards derived from the
smoking of the stronger, shorter, and less-filtered cigarettes of 20 to 30
years ago.
The standard regimen appears to have been born in the laboratory of the
American Tobacco Company (ATC), Richmond, Virginia, in the 1930s
(Bradford et al. 1936). AT the time, ATC dominated the manufacture of
cigarettes in the United States (Overton 1981). The Bradford et al.
article proposed to create a standardized smoking machine procedure
“in the interest of economy of research, and harmony among the various
investigators” (p. 836).
In a book published to promote an ATC brand at the 1939 New York
World’s Fair, Flannagen (1938) describes a tour of the ATC analytical
laboratory. The author appears to have seen the Bradford et al.
equipment in action: “Fascinated, I soon learned [from his guides] some
interesting facts about smoking cigarettes. The average puff, for
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instance, contains 35 cubic centimeters of smoke, and the smoke moves
through the cigarette at the rate of 17 cubic centimeters per second.
The normal time between puffs is 60 seconds.... All of these human
phenomena and others were reproduced faithfully by the machine” (p.
78).
Inspecting the original Bradford et al. paper, however, one finds the
empirical basis for these “average” and “normal” values of smoking
behavior lies in a study by Pfyl (1933). In 7 subjects, Pfyl had found puff
volumes of from 29 to 61 ml (Mean = 42.3, SD = 10.4). (Though
commonly described as puff volumes, Pfyl’s values were for air intake
into the cigarette during a puff; Schur and Rickards (1957) found that an
air intake of 35 ml was equivalent to a smoke gas phase volume, i.e.,
the modern smoking machine’s puff volume, of 42 ml--a 20% difference.)
Pfyl set his own smoking machine to take a 2 sec, 40 ml puff twice a
minute. Bradford et al. commented that Pfyl’s smokers probably smoked
more vigorously than normal because of the experimental setting, and
the authors close their article by stating “The present writers’ arbitrarily
selected rate IS a 35-cc. puff of 2-second duration taken once a minute”
[emphasis added] (p. 839). Earlier in their article, the authors do give
some rationale for the selection of their machine settings: 1) a puff
should not be larger than the capacity of the mouth, but “should be large
enough to produce a generous smoke,” (p. 838), 2) the time between puffs
should be long enough to allow the coal to return to a free-burning
condition, and 3) the puff should neither be too rapid nor too slow.
For those Interested in smoking behavior, the standard assay lacks the
empirical, objective pedigree that has been assumed. Standard tar and
nicotine assays were born in the tobacco science laboratory out of a
need to precisely quantify cigarette smoke. Bradford et al. (1936) and
their colleagues in tobacco science should not be faulted for devising a
procedure to meet their own special needs. It has long been clear that
smoke yields depend on the exact manner in which a cigarette is smoked.
To do analytical research on cigarette smoke, an agreed upon standard
smoking procedure was mandatory so that conditions could be
reproducible from laboratory to laboratory and from experiment to
experiment. The idea, then, was not to come up with a model of average
human smoking behavior, but rather to arrive at a reasonable, fixed and
reproducible way of putting cigarettes through their paces so that
chemical and physical properties could be examined (see Wynder and
Hoffmann 1967).
Note that the standard procedure was created primarily to compare
quite similar cigarettes when smoked in exactly the same way. Between
the 1930s and the 1950s, most cigarettes were 70 mm long. The modern
cigarette market has all but forgotten the early best-sellers and includes
mainly filter cigarettes (both ventilated and unventilated) that are 80
mm (in boxes), 85 mm (in softpack), 100, or even 120 mm long. The
complex issues of varying smoking habits, the behavioral pharmacology
and behavioural toxicology of smoking, and reduced-risk smoking were
not salient at the outset of the standard assays. The smoking and health
industry had not attained the prestige and Influence of the present day.
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AVERAGE SMOKING BEHAVIOR AND STANDARD YIELDS
The writings on smoking machine tests before 1960 show that little
effort was made to determine “average” puffing values for a
representative sample of smokers. Puffing measures were mainly taken
on convenient samples (e.g., Schur and Rickards 1957). A detailed
review of measurements of average human smoking behavior will not be
attempted. Moody (1980) provides a brief review of earlier findings, and
his own study employs the largest sample of smokers (517 adult medical
patients). HIS laboratory procedures find average puff durations of 2.12
sec (SD = 0.881, puff volumes of 43.5 ml (SD = 21.91, puff intervals of
25.8 sec (SD = 17.1). One can estimate from this research that the
standard puff IS 20% smaller, 6% faster, and 133% less frequent than
that of the “average” smoker in the laboratory. Of course, as noted by
Bradford et al. (1936), the behavioral laboratory does appear to lead to
more intensive smoking than do more natural smoking conditions (e.g.,
Russell et al. 1982). There are probably as many “average” smoking
behaviors as there are distinct psychological settings for smoking. For
example, poorer, older male smokers are more intense smokers per
cigarette than are richer, younger males (Moody 1980).
Even if a valid or accurate estimate of average smoking behavior IS
attainable, it does not follow that it would be sufficiently reliable or
precise to give many smokers information about their own idiosyncratic
tar and nicotine yields from a given brand. The ideal average smoker
may always be an inadequate stand-m for individual smokers; an average
value tells you about the behavior of other members of the population to
the extent that the other members of the population cluster in close
proximity to the average. From Moody (1980), one can estimate that
68% of smokers have puff volumes that are between 21.6 and 65.4 ml;
the coefficients of variation are substantial: 41.5% for puff duration,
50.3% for puff volume, and 66.2% for puff interval. The variability of
human smoking behavior IS large enough that standard yields do not, on
their own, provide a good indication of actual yields to individual
smokers (Green 1978; Kozlowski 1981b). A valid average tar and
nicotine yield might, however, be useful for epidemiological studies on
dose-disease relationships in large samples of smokers (Kozlowski et al.
1982c).
OTHER PROBLEMS WITH THE STANDARD SMOKING MACHINE
To understand the deficiencies of standard tar and nicotine assays, it
helps to understand the strategies involved in the construction of lower-
yield cigarettes. The standard procedure, one discovers, provides the
hurdles, while design variants provide ways around the hurdles. For the
most part, standard tar and nicotine yields are altered in only two ways.
Cigarettes are constructed to either a) burn faster and therefore have
fewer puffs taken during the standard one puff per minute procedure or
b) produce lower concentration smoke per puff. Table 1 outlines some
common manufacturing techniques for reducing standard tar and nicotine
yields.
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Number of Puffs
Remember that the standard procedure does not specify a number of
puffs to be taken on the cigarette, but rather a puffing-rate. Changes in
total burn-time seem to have been a major strategy responsible for yield
reductions between 1967 and 1975 (Kozlowski et al. 1980b). Dropping
just one puff from a 20 mg tar cigarette can reduce the yield by 2 to 3
mg.
Tobacco manufacturers, themselves, argued that the FTC cigarette tests
should make systematic use of information about puff variations from
brand to brand: “...the failure to report results both on an average per
puff and average per cigarette basis would create bias and have
unwarranted adverse competitive effects.” (American Tobacco Company,
Brown & Williamson Tobacco Corporation, Liggett and Myers Tobacco
Company, Philip Morris Incorporated, and R.J. Reynolds Tobacco
Company, December 20, 1966, p. 10). (See also Keith and Newsome
1958). When one appreciates that a standard procedure caused 6.9 puffs
to be taken on one filter king size (85 mm) cigarette and 11.5 puffs on
another filter king size (85 mm) cigarette (a difference of 66.6%, Jenkins
et al. 1979), it IS unfortunate that the warning by the tobacco companies
was not heeded. If 120 mm cigarettes are considered, machine puffs
ranged from 6.9 to 16.3 (a difference of 136%) (Jenkins et al. 1979): This
means that a pack-a-day, puff-per-minute smoker of the 16.3 puff
cigarette would be taking 136% more puffs per day than would the same
kind of smoker of the 6.9 puff cigarette, yet nominally they would both
be pack-a-day smokers.
TABLE 1
REDUCING STANDARD TAR AND NICOTINE YIELDS
A. REDUCE NUMBER OF PUFFS PER CIGARETTE BY
1. decreasing length of available tobacco column with
a. longer overwraps
b. longer filters
2. increasing the burn-rate of column with
a. chemical additives
b. higher porosity paper
c. less tobacco (wt/vol)
B. REDUCE CONCENTRATION PER PUFF BY
1. increasing filter-efficiency with
a. ventilated-filters
b. longer filters
c. denser filters
2. increasing porosity of cigarette paper
3. decreasing tobacco leaf (wt/vol) with
a. reconstituted sheet tobacco
b. puffed tobaccos
c. flavorings and additives
4. increasing the use of lower-yields tobacco strains
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The Behavioral Problem of Vent-Blocking
Unquestionably, the most dramatic yield reductions in recent cigarettes
are due to the effects of filter ventilation. The modern ultra-low-yield
cigarette (< 6 mg tar) IS a ventilated-filter cigarette. On a 1 mg tar
cigarette a vented filter can cause each puff to be diluted by about 80%
with ambient air (Kozlowski 1981c). In addition to affording all the
traditional opportunities for compensatory smoking (e.g., more
cigarettes, larger puffs, more frequent puffs), vented-filter cigarettes
can have the air intake holes on the filters blocked by smokers’ lips or
fingers (Kozlowski 1983). Kozlowski et al. (1982b) found that about 40%
of them sample of long-term smokers of vented cigarettes blocked the
vents to a substantial degree. Table 2 shows how dramatically hole-
blocking, coupled with somewhat larger and more frequent puffs, can
increase tar, nicotine, and carbon monoxide yields on selected “lowest”
yield cigarettes from three countries. Whereas smokers are free to
block filter vents, smoking-machine rules rigidly specify the amount of
filter inserted into the holder: Air intake holes can not be blocked by
the “smoker” in the course of a standard assay.
TABLE 2
EFFECTS OF INTENSIVE SMOKING ON LOWEST YIELDS
COUNTRY STANDARD ASSAY INTENSIVE ASSAY
TAR NIC C O TAR NIC CO
U.K. 1 0.1 1 29 2.2 21
CANADA 1 0.1 2 15 1.1 24
U.S. 1 0.1 2 12 0.8 18
The intensive procedure was a 2.4 sec, 47 ml puff every 44 sec;
all values are in mg; for more data and details about brands,
see Kozlowski et al.
Addiction. Reprinted by permission.
(1982b). © 1982, British Journal of
GOING BEYOND THE STANDARD ASSAY
The standard tar and nicotine numbers result from an artificial and
unsatisfying “method of convenience.” Standard ratings offer more to
the tobacco scientist than the behavioral scientist, yet they are often
taken at face value by behavioral scientists, as i they were almost
perfect predictors of actual yields achieved by a given smoker of a given
cigarette (e.g., Foxx and Brown 1979).
Armed with reasonable standards, the tobacco science field over the
years has become invested in maintaining the settings of a 2 sec, 35 ml
puff, once a minute. Tampering with the standard puffing procedure, it
has been argued, would disrupt the continuity and historical
comparability of much of tobacco science. Despite the weaknesses of
such arguments, it might be more realistic to propose that an improved
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procedure should be added alongside the sanctified standard, rather than
to urge the complete abandonment of the standard. The spent cigarette
butt of a filter cigarette is in a unique position to supply information
about the actual yield of tar and nicotine from that cigarette “Yield”
here refers essentially to mainstream smoke, or, in other words, the
smoke drawn through the filter as a result of puffing.
The study of tar and nicotine deliveries should not be mistaken for the
study of the burden of tar and nicotine in the smoker’s body. Exposure at
critical tissue sites IS dependent on myriad factors (e.g., inhalation,
levels of drug-metabolizing enzymes), and it is unrealistic to expect that
any measure of how much smoke has issued from the smoker end of a
cigarette can be anything but a rough indicator of pharmacologically or
toxicologically significant exposure.
USING PHYSICAL EVIDENCE TO DETECT ACTUAL YIELDS
The remainder of this paper focuses on what can be learned from the
tracks of smoke (tar stains) left behind in cigarette filters. Even a
novice can read these tracks, to get an idea of the actual tar and
nicotine yields of cigarettes. A skilled reader of sign, using a camera or
equipment for chemical analysis, can achieve a more objective, yet still
unobstrusive, measure of what has been delivered through the smoker
end of a cigarette. Cigarette filters can provide useful information
about how an individual cigarette has been smoked, and the physical
evidence of these filters can help in the estimate of the actual tar and
nicotine deliveries of cigarettes. The resultant measures are
approximate indicators of behaviors and yields that are difficult to
estimate in any more practical and less expensive way. Filter analyses
can provide a summary indication of the puffing behavior that has
occurred, but these analyses may say little about how the smoke was
used after the puffs were taken.
USING STAIN PATTERN TO DETECT HOLE-BLOCKING
About 40% of current hole blockers seemed to be unaware that they did
block the vents (Kozlowski et al. 1982b). Those who were aware of
blocking the holes appeared to think their actions served mostly to make
the cigarette easier to light and more flavorful, and these smokers (and
many researchers) were ignorant of the powerful effects on tar, nicotine,
and carbon monoxide yields (see Table 2).
Most ventilated filters have air-intake holes that feed the diluting air
directly into the cellulose acetate filter. In these cigarettes, when the
holes are blocked, a bull’s-eye tar stain pattern will be seen in the
smoker end the filter, surrounded by a ring of unstained filter (see Figure
1). Insofar as the vents are blocked, the tar stain extends to the edge of
the filter and, in the extreme, forms a uniform field of tar stain on the
end of the filter. If the filter vents were blocked by a pinch of the
fingers that occluded the same opposing set of holes on each puff, the
tar stain would form a band between the blocked holes. Blocking on a
few puffs would likely cause a somewhat irregular tar stain, with a
darker central region. Incidentally, lipstick stains over the vent holes
also give physical evidence of hole-blocking.
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FILTER SECTIONS
SIDE VIEW END VIEW
FIGURE 1 - shows the progressive staining of the proximal end
(A & D) of the filter downstream from the perforation line (C)
as the number of holes blocked increases from one in filter 1,
to a partial block in filter 2, and a complete block in filter
3. B is the distal end of the filter. Kozlouski et al. 1980a.
© 1982, American Public Health Association. Reprinted by
permission.
Photographic records can be made of the stain patterns, to aid in scoring
the spent filters. At the present time, it is best to try to sort a smoking
episode into one of three categories: 1) the holes were extensively
blocked, 2) the holes were not at all blocked, 3) the holes were partially
or occasionally blocked. The discrimination is most reliable between the
first and second categories; avoiding the approaching coal can cause
finger-blocking on the last few puffs and, hence, an intermediate stain
pattern (Lombardo et al. 1983). More precise quantification will have to
await the development of techniques for scanning and scoring carefully-
controlled photographs of butts.
Knowledge of hole-blocking can inform smokers and researchers of
egregious misuse of a low-yield cigarette If the vents have not been
blocked, it does not ensure that the cigarette was not oversmoked in
some more traditional manner. A pamphlet (Kozlowski 1982) has been
prepared, to explain to consumers some of the complex risks involved
with switching to low-yield cigarettes.
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USING STAIN INTENSITY TO DETECT ACTUAL YIELDS
Chemical assays for residual nicotine in spent filters have been used to
provide estimates of “mouth level exposure” or yields (e.g., Forbes et al.
1976; Kozlowski 1976). These estimates depend on the assumption of a
constant filter efficiency. Filter efficiency refers roughly to the
percentage of smoke ingredient presented to the filter that is trapped in
the filter. Knowing the filter efficiency and the amount of nicotine (or
other marking ingredient) trapped in the filter, one can calculate the
amount of nicotine that passed through the filter. Unfortunately, filter
efficiency can be altered, especially by factors that Influence puff
velocity (e.g., Creighton and Lewis 1978). The faster the puff velocity,
the less efficient the filter. (Note that the Moody 1980, study would
have a puff velocity of 20.5 ml/sec, whereas the standard assay has a
17.5 ml/sec puff velocity--a 17% difference.) Since blocking vent holes
causes an increase in puff velocity through the filter and a resultant and
substantial drop in filter efficiency, evidence of hole-blocking should
disqualify a butt from this method of estimating yields.
A color-matching technique (called the CMT scale) IS being developed,
employing the same general principles as the butt-nicotine estimates of
mouth-level exposure. The CMT scale IS also dependent on the
assumption of constant filter efficiency, and, because of this intrinsic
limitation, it is likely, at best, to provide ballpark estimates of tar and
nicotine yields, rather than pinpoint figures. Tar stains are visible and
the intensity of the “color” of a tar stain Increases as the amount of tar
Increases.
Kozlowski (1981b) proposed that visible differences in tar stains could be
used to detect how much a smoker had puffed on a given cigarette, and
showed that individuals could tell faultlessly that a 12-puff butt was
darker than a 6-puff. Kozlowski et al. (1982a) showed that individuals
can make even finer discriminations of tar variations, if they rate
“lightness or darkness in color” by comparing butts to a scale made up of
colored papers.
The original CMT scale was created by matching specially smoked butts
with colored papers from the Pantone by Letraset Color-matching
System. Three prototype butts were prepared: one resulting from a
light smoke (a 2 sec, 25 ml puff/120 sec), one from a standard smoke, and
one from a heavy smoke (a 2.5 sec, 45 ml puff/20 sec). A best-selling
filter cigarette (standard yield: 0.9 mg nicotine, 16 mg tar, in about 10
puffs) was used in all phases of this project. The optimal, though not
perfect, matches were, respectively, a pale yellow (Pantone 127 U), a
greenish brown (Pantone 117 U), and a brown (Pantone 139 U). The
“light,” “standard,” and “heavy” colors were mounted at points designated
as 2, 5, and 8 on a 0 to 10 scale (see Kozlowski et al. 1982a, for details
and a picture of the instrument).
To supply filters for rating, 5 to 16 approximately standard puffs were
taken on cigarettes of the same brand. This puff manipulation was
designed to produce a substantial, but reasonable, manipulation of tar
yields. The difference in yields from 5 to 16 puffs was estimated to be
18 mg tar and 1 mg nicotine. Eleven adults gave each filter a score on
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the CMT scale. Table 3 shows a summary of the results (the data have
been smoothed somewhat by averaging scores across subjects and across
adjacent pairs of puff numbers). The raters were clearly able to do the
task (Linear regression, Puffs = 3.1 (Rating) -6.0; r = .996). Correlations
between numbers of puffs and CMT score for the individual participants
were .99, .98, .97, .96, (N : 4), .90, .83, .82 (Ps < .05, 2 tailed) and .73
(p < .10).
TABLE 3
EFFECT OF NUMBER OF PUFFS TAKEN ON CMT SCORES
STANDARD PUFFS TAKEN
CMT SCORE 5-6 7-8 9-10 11-12 13-14 15-16
MEAN 3.6 4.5 4.9 5.5 6.2 6.9
S.D. 1.0 1.0 0.8 1.0 0.8 0.7
Kozlowski et al. 1982a. © 1982, American Public Health
Association. Reprinted by permission.
Hopefully, the CMT scale can be developed to provide smokers with, in
effect, a speedometer and an odometer to aid them in monitoring their
own tar and nicotine yields. The CMT scale can be combined with
information about the range of possible yields from a brand and, at the
same time, give smokers some means of gauging where they fall within
that range.
Since this scale IS based on a printer’s color-matching system, it could be
practically applied as part of cigarette packaging, match-book covers, or
supplementary pamphlets on tar and nicotine yields. Apart from giving
the consumer some information on actual yields, there may be additional
benefits in avoiding a presentation of yields that gives only one rating
number per brand. The mode of presenting tar information using a CMT
system shows graphically that actual yields depend on amount smoked.
A FINAL COMMENT
For anyone Interested in human smoking behavior, the standard smoking-
machine tests for tar and nicotine yields are so Inadequate that it is easy
to propose improvements. It is not easy, however, to know how much
these improvements might actually help cigarette consumers and
smoking researchers; and, in the long run, it is even harder to know how
these new hurdles might be gotten round by future changes in either
cigarettes construction or smoking-machine procedures.
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Measurement of Some
Topographical Aspects of
Smoking in the Natural
Environment
Roy W. Pickens, Ph.D., Steven W. Gust, Ph.D.,
Philip M. Catchings, Ph.D., and Date S. Svikis, B.A.
A major problem in smoking research has been measurement of the
behavior. Instead of a simple response as originally assumed, smok-
ing appears to be a relatively complex behavior. It is composed of
a number of different responses, which include frequency (number of
cigarettes smoked per day, number of puffs per cigarette), duration-
al (puff duration, cigarette duration, interpuff interval, inter-
cigarette interval), and volumetric (puff volume, inhalation vol-
ume) components. Together these components comprise a topography
that determines the individual’s actual smoke exposure (Frederik-
sen et al. 1977).
In smoking research it is important to employ as many measures of
smoking topography as possible in estimating smoke exposure (Grif-
fiths and Henningfield 1982). Measurement of a single aspect of
smoking will not suffice for most research studies. Different indi-
viduals may have identical values on certain topographical measures
but differ widely on others and therefore have different levels of
actual smoke exposure. It is also important to employ multiple
topographical measures in studies of factors controlling smoking
behavior, because at least some of the responses comprising smok-
ing behavior appear to be functionally interrelated. When one com-
ponent of smoking behavior is experimentally manipulated, changes
occurring in that component may be partially offset by compensatory
changes in other components of the behavior (Gust et al. in press).
Precise measurement of smoking topography is therefore essential to
any scientific study of smoking behavior.
For this reason previous studies of smoking topography have been
confined largely to the experimental laboratory. This has been due
primarily to lack of suitable recording devices for measurement of
multiple components of smoking topography in the natural environ-
ment (Frederiksen et al. 1979). Previous studies of smoking topo-
graphy in the natural environment have been limited almost entirely
to single measures of smoking behavior collected by self-report
records, or to a limited number of multiple measures of smoking
behavior determined by direct observation. For the experimental
analysis of smoking behavior, however, self-report records are not
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sufficiently precise and direct observation is impractical. While
attempts to determine the effects of experimental manipulations on
smoking behavior in the natural environment have also employed bio-
chemical measures to track smoking behavior (Moss and Prue 1982),
such measures have lacked the sensitivity and specificity that is
required to measure cigarette-to-cigarette changes in smoking behav-
ior. In addition, such measures have shown considerable variabi-
lity between subjects and consequently have not proven reliable in
predicting individual smoking rates.
We have recently developed a small, portable, solid-state device
that can be used in the natural environment to obtain several meas-
ures of smoking topography. This device is about the size and
weight of a small transistor radio and can be easily clipped onto a
belt or carried in a coat pocket or purse. It will measure and
record individual puff durations, interpuff intervals, cigarette
durations, and intercigarette intervals, and will also count both
cigarettes/day and puffs/cigarette. The device employs microelec-
tronic technology and can measure time intervals as short as 0.1
sec and as long as 18.1 hours in each of its 2048 memory cells.
Assuming 10 puffs per cigarette, the device has the capacity for
precisely measuring all frequency and durational aspects of smoking
topography for over 100 individual cigarettes over a two-day per-
iod. This report describes the operation of the device and com-
puter software that has been developed to facilitate its use.
Studies on accuracy and reliability of the device will also be
reported.
AMBULATORY SMOKING RECORDER
The recorder is an electronic device that precisely measures the
duration of consecutive puffs and pauses that occur in cigarette
smoking. Short pauses separate puffs occurring during the smoking
of a single cigarette, while longer pauses separate puffs into indi-
vidual cigarettes. By measuring the duration of these puffs and
pauses, it is possible to obtain all of the topographical measures
of smoking described above. In brief, the device functions as fol-
lows. Constant-rate pulses from a time-base generator are counted
until onset of a puff. When the puff begins, the number of pulses
accumulated in the counter is stored in a memory cell, the counter
is reset, and counting of pulses from the time-base generator re-
sumes. When the puff ends, the number of counts accumulated in the
counter since the start of the puff is stored in another memory
cell, the counter is reset, and counting resumes. This continues
until onset of the next puff, when the number of counts accumulated
is stored in yet another memory cell, etc. Thus, both the onset
and termination of a puff cause accumulated counts to be stored in
memory cells, with the number of counts appearing in each cell cor-
responding to the duration of the smoking event. Timing continues
in this fashion until the battery supplying power to the device is
exhausted (56 hrs minimum) or all memory cells have been utilized
(2048).
Specifically, the recorder consists of a standard cigarette holder
that is connected via plastic tubing to a small metal box (1 x 4 x
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5 in) which the subject carries either in hand or attached to a
waist belt. The weight of the device is approximately one pound.
The cigarette holder (Tar Gard, #1274, Venturi Corp.) is screwed
into one end of a 7/8-in length of 3/8-in diameter brass tubing,
with the other end of the brass tubing holding the cigarette that
is to be smoked. A 1/4-in length of stainless steel tubing is sol-
dered into a hole drilled into the side of the brass tubing. One
end of a 24-in length of plastic tubing (1/16-in I.D., 1/8-in O.D.,
1/32-in wall) is attached to the stainless steel tubing, and the
other end of the plastic tubing is attached to a pressure switch
(Model 505-3, 0.5-in pressure to activate, Coventry Corp.) located
inside the metal box. In addition to the pressure switch, the
metal box contains a rechargeable nickel-cadmium battery (4.8 volts,
.75 amp hrs, Gould Battery Corp.), and printed circuit boards con-
taining microelectronic hardware necessary for measurement and
storage of the durations of the successive smoking events.
To obtain the time measurements, the output of a 3.58 MHz quartz
crystal (ECG 358) is fed through oscillator/dividers (FM5369) into
counters (CD4040) to yield a 1/4 Hz (slow) and 10 Hz (fast) time
base. A separate counter controls a series of multiplexers (74C1571
which direct the time-base output to sequential memory cells. The
memory cells are 16 x 2048 bits of random access low-power CMOS
memory (6514B5261). Initially, only the output from the fast time
base (10 counts/sec) is directed into the memory cells; however,
after 409.6 sec the output from the slow time base (1/4 counts/set)
is directed into the memory cells. Thus, during the first 6 min,
50 sec of an interval, the resolution of the device is .1 sec,
while after this time the resolution is 4 sec. Of each 16-bit data
word, the upper 2 bits serve as flags to indicate whether the event
was a puff or pause, and whether the time base was in the fast or
slow mode. The remaining 14 bits of the 16-bit word are reserved
for interval timing function. Initialization of the memory cells
and retrieval of data from the device is under software control
through interface with an Apple II Plus microcomputer via a 6522
Parallel Interface board (John Bell Engineering, Inc., Part No.
79-295) and ribbon cable.
SOFTWARE SUPPORTING RECORDER
The software is written in Pascal programming language and requires
an Apple microcomputer with 64K of RAM memory, a Thunderclock Plus
card for time-keeping function, and two disk drives for data stor-
age and program execution.
The primary software program has three functions: (1) to establish
and maintain data files for individual research subjects; (2) to
initialize and retrieve data from memory cells of the device; and
(3) to display and analyze data obtained. In the first function,
the program allows for Pascal-formatted diskettes to be initialized
for use in data recording, subject names to be added and deleted to
a master directory file, and diskette numbers to be assigned to
subjects for data recording. In the second function, the program
initializes (sets to zero) the memory cells of the device prior to
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subject issue and records the time of initialization in the sub-
ject’s file. When the recorder is returned by the subject, the
program writes the collected data to a diskette file and writes the
time of the data collection in the subject’s file. In the third
function, the program displays data from a diskette file to a
screen monitor or printer, allows the experimenter to designate
memory cells that are to be interpreted by the computer as the
start and end of individual cigarettes, and performs a summary ana-
lysis of the data (see below). Since a certain amount of pressure
switch chatter will occasionally occur with such a system (usually
towards the end of a puff), the program allows a minimum pause
value to be specified which will result in pauses less than a given
value being combined with adjoining puff values. For example, we
have found that pause cutoff values of 0.5 sec will accurately eli-
minate most problems associated with switch chatter, giving a more
accurate number of puffs per cigarette and a more accurate measure
of puff time. Presently, the program is undergoing a revision to
permit the automatic delineation of cigarettes from raw puff/pause
data, with pauses longer than a given value being considered by the
computer as intercigarette intervals.
A sample of the summarized data obtained from one subject is shown
in figure 1. The subject’s name has been removed for anonymity.
The raw data collected was stored as Record 1 on Disk 002A. The
recorder was initialized at 16:44 (4:44 pm) on May 15, 1983, and
the minimum pause duration for data analysis was set at 1.0 sec.
The first column shows cigarette number; the second column shows
the starting time of the cigarette; the third column shows the sec-
onds spent in smoking the cigarette (cigarette interval); the fourth
and fifth columns show the memory cells that delineate the cigar-
ette event based on data entered earlier by the experimenter after
inspection of a printout of the raw data (not shown); the sixth
column shows number of puffs per cigarette; the seventh column
shows the total duration in seconds of all puffs taken on the cigar-
ette (total puffing time); the eighth column shows total pause dur-
ation in seconds for the cigarette; the ninth and tenth columns
show the mean puff and pause durations, respectively, in seconds
for each cigarette; the eleventh and twelfth columns show inter-
cigarette times in seconds and minutes, respectively. Following
the individual cigarette data, mean values for the entire session
(in this case 48 hrs) are given along with standard errors.
Other software has been developed for testing the timing accuracy
of the device and for determining the status of memory cells in the
device.
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FIGURE 1. Printout of summarized topographical data
from subject using the Ambulatory Smoking Recorder.
(See text for description of record.)
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TESTING OF THE DEVICE
Timing Accuracy of Device
To determine the timing accuracy of the device, electronic program-
ming equipment was programmed to input electronic pulses of known
duration to the device for comparison with data output from the
device. The duration of intervals fed into the recording device
was of the range that is typical of smokers’ puff durations. A
precision time-base in conjunction with a predetermining counter
(Coulbourn Instruments S51-10 and S43-30, respectively), opened and
closed a switch connected to the digital memory unit of the record-
ing device at intervals set by the experimenter. When the timer
was set at 1.0 second, the switch closure changed every second,
resulting in intervals of 1 second “on” and 1 second “off” which
the recording device interpreted as “puff” and “interpuff” inter-
vals, respectively. The digital memory unit’s accuracy was tested
by recording a minimum of 50 consecutive time intervals at the fol-
lowing timer settings: 3.0, 2.0, 1.0, 0.9, 0.8, 0.7, 0.6, 0.5,
0.4, 0.3, 0.2, and 0.1 seconds. In addition, the device was tested
with 30 consecutive 20.0-second intervals. No differences were
found between input and output values. (Steven Morgan, personal
communication).
Validity of Device
To determine if the device was yielding results representative of
the subject’s actual smoking behavior, a study was conducted com-
paring the topograhical data collected by the smoking recorder with
similar data collected simultaneously by trained observers. Eight
paid volunteers? all patients on the Clinical Investigations Unit,
University of Minnesota Hospitals? served as subjects. Subjects
were observed while smoking one cigarette twice each day for eight
days. The morning session took place at approximately 9:30, the
afternoon session at approximately 2:30. Subjects were observed
through a one-way mirror while they smoked in a sound-attenuating,
ventilated test chamber. An observer was present during all 16
observation sessions. A total of four observers were employed,
each monitoring at least two subjects while they each smoked at
least two cigarettes. During each test session the observer elec-
tronically timed the duration of the cigarette interval (measured
from the time a flame was held to the end of the cigarette until
the time the cigarette was extinguished). The observer also manu-
ally closed a pushbutton switch for the duration that the cigarette
was laced in the subject’s mouth and observed to glow (puff dura-
tion).
For eight of the 16 observation sessions, the subjects used the
smoking recorder in smoking (once each day, either in the morning
or afternoon). Whether or not the recorder was used in the morning
or afternoon was determined by a counterbalanced design. During
observation sessions a chart recorder (Esterline Angus Corp.) with
a chart speed of 12-in/min was used to record smoking topography.
One channel of the recorder was connected to the pushbutton switch
67
operated by the observer. A second channel, used only during obser-
vations in which the subject used the smoking recorder, was con-
nected to the pressure switch of the smoking recorder.
There was no significant difference between the simultaneously
collected measures. There was 100% agreement between observer and
smoking recorder data for number of cigarettes smoked and mean num-
ber of puffs per cigarette. However, across subjects, the dura-
tions measured by the observers for puff interval were slightly
larger than those measured by the smoking recorder (1.66 sec vs.
1.54 sec, respectively). The durations of interpuff intervals were
also longer for observers than for the recorder (19.17 sec vs.
18.72 sec, respectively). Across the eight subjects, the mean dis-
crepancy per puff between the recorder and the observational data
was 0.12 seconds. Therefore, the puff durations measured by the
observers were on the average 8% larger. For interpuff intervals,
the mean discrepancy was 0.45 seconds. Therefore, the interpuff
intervals measured by the observers were on the average 2% larger.
To analyze further the discrepancies obtained between observer and
recorder data, observers were asked to monitor a more discrete stim-
ulus than the glow of a cigarette tip. Three observers monitored
the duration of illumination of a small, red stimulus light (.75-in
diameter red dome covering a #327 lamp located atop a 2 x 3 x S-in
metal box in the subject chamber). The observers closed a switch
when the light was illuminated and released the switch when the
light was extinguished. The on-off pattern of the light was pro-
grammed to replicate a typical smoking pattern. One channel of an
event recorder charted the on-off pattern of the stimulus light;
another channel recorded the on-off pattern of the observers’
switch.
Absolute discrepancies between channels were calculated for each
on-off data pair. The mean discrepancy for light-on was .09 sec-
onds (relative to .14 seconds for puffs in the previous study) and
the mean discrepancy per light-off was .12 seconds (relative to .34
seconds for pauses in the previous study). Thus, even on a simple
observational task, significant rater error was found. Rater error
could be expected to increase as the discrimination between “on”
and “off” became more difficult, as in observing the glowing tip in
cigarette smoking (Steven Morgan, personal communication).
Effects of Use of the Recorder on Smoking Behavior
To determine the effects of using the smoking recorder on the sub-
jects’ smoking behavior, the smoking pattern of eight subjects was
monitored over eight consecutive days while they lived as inpa-
tients on the Clinical Investigations Unit of University of Minne-
sota Hospitals. Subjects were required to record to the nearest
minute the exact time when each cigarette was lit, using forms pro-
vided. On four of the eight days, the subject used the smoking
recorder in smoking all cigarettes. The order of the days using
the device was counterbalanced across subjects. Twice each day the
subjects were observed while smoking a cigarette in the test cham-
68
ber (described above). An observer recorded the time and duration
of each cigarette and manually closed an electrical switch for the
duration of each puff, recording the event on an event recorder.
Using the smoking recorder resulted in a small, but statistically
significant decrease in the number of cigarettes smoked per day.
When using the recording device, subjects smoked an average of
21.33 cigarettes per day; without the device, subjects smoked an
average of 25.72 cigarettes per day (t = 3.93. df = 62, p < 0.001).
Furthermore, this trend was consistent across subjects, with each
subject smoking more cigarettes on non-use days. Observations made
in the laboratory on days with and without the recorder were com-
pared to determine the effect of the smoking recorder on smoking
topography. There was a statistically significant main effect of
recorder use on number of puffs per cigarette and mean total puf-
fing time per cigarette. When using the smoking recorder subjects
tended to take slightly more puffs per cigarette (15.8 vs. 13.3)
and to have a slightly longer mean total puffing time per cigarette
(26.2 seconds vs. 22.1). While use of the recorder was expected to
reduce number of cigarettes smoked (as almost all such procedures
have been found to do in behavioral research), the increase in num-
ber of puffs per cigarette and mean total puffing time may reflect
a titration effect, in which reduction in number of cigarettes per
day is compensated for by an increase in the number of puffs taken
per cigarette and by an increase in total puffing time per cigar-
ette. This is supported by the finding that use of the recorder
had no significant effect on total daily smoke exposure (derived by
multiplying number of cigarettes per day by number of puffs per
cigarette by mean puff duration).
Self-Report/Recorder Agreement in the Natural Environment
In previous studies the accuracy and reliability of the smoking re-
corder was tested in a hospital environment. In the present study,
testing of the device was extended to the natural environment. Sub-
jects were issued the smoking recorder on Monday evening and in-
structed to use the recorder in smoking all cigarettes until return-
ing to the laboratory at the same time two days later. Subjects
were asked to keep a written record of the time each cigarette was
smoked. The record was kept on a bright blue 3 X S-in card that
was folded and inserted beneath the cellophane wrapper of the sub-
ject’s cigarette pack. Subjects were asked to record the time to
the nearest minute that each cigarette was lit.
A high degree of agreement was found between the subjects’ self-
report records and data obtained from the smoking recorder. Figure
2 shows the difference in minutes between self-report and recorder
data for a representative subject in the study. The bar graph
shows the magnitude and direction of the difference between self-
report and recorder measures. For each cigarette, specific values
obtained by self-report and recorder are shown above and below each
graph point. Values obtained with the smoking recorder were rounded
to the nearest minute. As shown in the figure, there was close
agreement between smoking times indicated on the self-report form
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FIGURE 2 Comparison of self-report and recorder values for
cigarette starting times.
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and smoking times indicated by analysis of the data from the smok-
ing recorder over the entire 48-hr period of the study. At least
some of the discrepancy could be related to the subject’s tendency
to round the self-report value to the nearest 5-min period, although
the subject was specifically instructed not to do so.
While smoking recorder and self-report data agreed closely concern-
ing the starting time of each cigarette, the smoking recorder data
can also be analyzed to provide additional information about cigar-
ette smoking. For example, all of the data shown in Figure 1 were
obtained as part of the present study. Thus, in addition to infor-
mation on number of cigarettes smoked and cigarette starting time,
which both self-report and smoking recorder can provide, the smok-
ing recorder can provide topographical data on cigarette duration,
number of puffs per cigarette, total puff time per cigarette, inter-
cigarette interval, etc.
SOME PRELIMINARY FINDINGS
Recent research from our laboratory suggests that situational and
mood factors may affect smoking topography in the natural environ-
ment. Subjects were issued the Ambulatory Smoking Recorder and
asked to use the device in smoking all cigarettes in the natural
environment over a 10-day period. (Subjects returned to the labor-
atory every two days for data retrieval and to obtain a recharged
battery.) Subjects were also asked to record the time, situation,
and internal state associated with each cigarette. When smoking
topography was compared for the most frequently occurring situa-
tions and mood states, large differences were found. Figure 3
shows total smoke exposure (total puffing time) for a single sub-
ject smoking the same brand of cigarette in different situations/
activities. Each data point represents the mean value for one
cigarette. Horizontal lines indicate the mean value for all cigar-
ettes in each situation. As can be seen, rather consistent effects
were found within each situation, and total smoke exposure (total
puffing time) differed widely across situations. Similar effects
have been found for subjects smoking under different mood states.
These results suggest that situation as well as mood may influence
smoking pattern in the natural environment (Steven Morgan, personal
communication).
APPLICATIONS OF THE DEVICE
The need for methodology to study smoking topography in the natural
environment is particularly acute for a number of reasons. Firstly,
smoking appears to be controlled by a number of situational and
internal factors not readily amenable to laboratory control. With
availability of the proper technology, the natural environment
would afford the ideal site for such studies. Secondly, the valid-
ity of results from laboratory studies of smoking behavior needs to
be ascertained. Attempts should be made to determine if findings
from laboratory studies will generalize to the natural environment.
Thirdly, the analysis of smoking topography in the natural environ-
ment may shed light on factors related to smoking treatment suc-
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SUBJECT 4
Activities
FIGURE 3. Total puff time per cigarette for subject when smoking
in various situations (activities). Each dot represents the mean
value for a single cigarette. Dashed lines represent mean value
for all cigarettes smoked under each condition.
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cess. Differences in smoking topography may explain why various
groups of smokers have different rates of treatment success.
Fourthly, such measures could provide a sensitive and inexpensive
estimate of smoke exposure, thereby providing a useful adjunct to
biochemical and other measures in estimating exposure to the toxins
in cigarette smoke. Finally, since smoking appears to be a form of
drug dependence, the study of smoking behavior in the natural envi-
ronment may provide data relevant to other drug dependencies, where
studies in the natural environment are more difficult to conduct.
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Data Collection and Question-
naire Design: Smoking Cessation
in Adults
Harry A. Lando, Ph.D.
Data collection and questionnaire design are significant to
both researchers and clinical practitioners in the field of adult
smoking cessation. Unfortunately, minimal standards for data
collection are typically neglected by public service and
proprietary programs and all too often are neglected by
researchers as well. The purpose of the current paper is not
to recommend new standards in this area. Instead, discussion
will focus upon some existing standards that profitably can be
applied in research and public service settings. Unfortunately,
extensive recommendations have been made in the past (e.g.,
International Union Against Cancer 1976; National Interagency
Council on Smoking and Health 1974) with little apparent effect
upon actual practice.
A major reason for failure to adhere to recommended standards may
be the fact that it is inconvenient to do so, especially for
public service and proprietary programs. One possibility would
be to develop a uniform one- to two-page questionnaire that could
be used by both researchers and practitioners. This
questionnaire would solicit information that is considered
essential in both contexts. Construction of such a uniform
questionnaire would in no way preclude collection of additional
information (as will be discussed below). It would, however,
provide commonalities in comparing subjects across both settings
and types of programs.
Previous standards may have provided relatively little incentive
for implementation, especially in public service settings. The
standards may in fact have been seen as somewhat coercive (e.g.,
these are the appropriate criteria , and any deviations from these
criteria are indicative of unsound methodology). The standards
may also have been viewed as overly extensive (the NICSH
recommendations required approximately 35 pages of text).
One possible approach in encouraging sound principles of data
collection might be to construct a simple and convenient
questionnaire with adequate reliability and validity. The
questionnaire should solicit minimal information that is
considered essential in both laboratory and field contexts. The
appeal of such a questionnaire might be considerably enhanced by
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including a brief interpretive section that would allow smokers
to score their own responses. The continued popularity of the
Smoker’s Self-Testing Kit (Ikard et al. 1969), despite limited
evidence for validity, is testimony to the attractiveness of this
type of approach.
NATIONAL CENTER FOR HEALTH EDUCATION GUIDELINES
The National Center for Health Education Code of Practice and
Standards for the Evaluation of Group Smoking Cessation Program
provide an excellent starting point in formulating
recommendations for data collection. These guidelines have been
adopted by such major public service and proprietary agencies as
the American Cancer Society, the American Health Foundation, the
American Heart Association, the Five-Day Plan to Stop Smoking,
and SmokEnders. However, at present it is unclear that these
guidelines are being followed in practice.
The NCHE guidelines are surprisingly stringent in a number of
respects. The criterion for success is complete abstention from
all forms of tobacco for a period of 1 year following treatment.
The Code of Practice notes that common definitions are needed to
provide both protection and assurance for smokers seeking
assistance in quitting. Almost all previous interventions, both
research and public service, have subscribed to a less rigorous
criterion in defining success.
The NCHE code of Practice also calls for conscientious record-
keeping. All smokers who are unavailable to followup must be
listed as smoking for purposes of evaluation. Furthermore,
participants include all of those smokers who attend at least the
first treatment session following orientation. This is a very
important point. Proprietary programs, in advertising
extravagant claims of success, appear in many cases to include
only those who complete treatment.
The NCHE guidelines assert that not only criteria for success,
but also accounting for program participants, followup, and
method of reporting outcome must all be standard. Definitions
are provided for terms, including in-term quitter, attrition
rate, long-term quitter, and recidivist. Although other outcome
measures may be reported in addition to complete abstention for
at least 1 year (e.g., abstinence for less than 1 year, switching
to pipes or cigars), the term “success” is not to be to be used
in conjunction with such measures.
Evaluation is to include: number of participants, number and/or
percentage who quit at the end of the intervention, and number
and/or percentage completing treatment who do not relapse. It is
also appropriate to state number and/or percentage of
participants entering the program who quit and did not relapse
during a 12-month period thereafter.
Because all participants who cannot be located at followup must
be counted as failures for purposes of data analysis, this
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provides a strong incentive to reach as many participants as
possible. The guidelines call for collection of sufficient
identifying characteristics for each participant to permit
contacting them at all followup intervals. Name, address, and
telephone number should be recorded, and employment address and
telephone number should also be noted where applicable. Although
not part of the NCHE standards, it is strongly recommended that
names, addresses, and telephone numbers of close friends or
relatives be solicited as well. These individuals can be
contacted to confirm self-reported abstinence and can provide
information on the whereabouts of participants who might
otherwise be lost to followup. Lando and McGovern (1982) found
these additional sources extremely helpful in locating
participants at long-term followups.
The NCHE standards permit followup by either mailed
questionnaires or telephone interviews. No provision is included
for independent validation of self-reported abstinence. Records
are to note data on tobacco use in any form for all participants
at beginning and termination of treatment and at l-year followup.
At this latter point, it should also be determined whether
participants smoked during the past year.
Detailed instructions are provided for calculating long-term
success rates. Participants who relapse, who refuse to respond,
or who are not located at followup are all counted as smoking.
Programs that do not report on their total enrollment are to
collect and report data for no fewer than 500 participants per
year. These should be all participants entering treatment
starting at a given point and continuing until the minimum total
(or some larger number) has been attained.
Basic identifying data are to be collected prior to the first
treatment session as part of registration to insure inclusion
of all participants. Dates of sessions and participants’
attendance are to be recorded. Information regarding smoking
rate and use of tobacco in any other form is also to be collected
at registration. Each case record must include identifying
information needed for purposes of followup.
American Lung Association Questionnaire
The American Lung Association in its Guide for Clinic Leaders
provides standardized forms and questionnaires for data
collection. Local chapters of the American Lung Association are
to maintain records for all clinics including name of
association, starting date of clinic, number of participants, and
name of clinic leader. An intake questionnaire, end of clinic
questionnaire, and 12-month followup questionnaire are also
provided, A sample letter is included for participants who
cannot be reached by telephone for followup. In addition, a
cumulative tally form is enclosed for recording information on
all participants through 12-month followup.
At intake, participants are asked current brand of cigarettes and
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level of smoking. They report identifying characteristics of
their brand (e.g., length, filtered vs. unfiltered, mentholated
vs. unmentholated). Information is solicited concerning age of
smoking onset, heaviest smoking consumption, and number and
method of previous attempts to quit. Use of tobacco in other
forms is also examined.
Participants report their longest period without smoking since
they began regular tobacco use. Furthermore, in addition to
information relating directly to smoking, participants are asked
about supportiveness of spouse, children, friends, and coworkers
as well as about prevalence of smoking among these categories of
individuals. They are asked about their own perceived readiness
to quit and about the number of clinic sessions they plan to
attend. Finally, they list basic demographic information
including age, sex, race, level of education, occupation, and
marital status.
Questionnaires administered at the end of treatment require
participants to report most and least helpful elements in
treatment. Current cigarette consumption is assessed, together
with use of tobacco in other forms. Evaluations of clinic
leaders and recommendations for improving the program are
solicited.
Twelve-month followup interviews are limited to minimum essential
data (projected time per interview is approximately 3 minutes).
Participants are asked whether they have smoked in the previous
month and if so about level of smoking. They are asked about
cigarette use since the termination of the clinic. Smokers
are to indicate cigarette consumption, brand, and brand
characteristics. All participants indicate date of last
cigarette. Use of other forms of tobacco is again assessed.
Finally, participants are asked to recall any elements from the
clinic that may have been especially helpful.
Evaluation
The NCHE guidelines and American Lung Association questionnaires
provide an excellent beginning in formulating recommendations for
data collection and questionnaire design. Especially encouraging
is the emphasis upon including all participants in reporting
outcomes (dropouts and participants who are not located must be
counted in computing abstinence rates) and upon l-year followup
as a minimum period for evaluating success. Conscientious
implementation of NCHE guidelines should be a major factor in
increasing the meaningfulness and comparability of data reported.
The guidelines are realistic and do not appear to impose an
excessive response burden upon public service or proprietary
organizations. As noted above, the requirement that
nonrespondents be counted as treatment failures provides a strong
incentive for careful recordkeeping and concerted efforts to
locate all participants. The major criticism of the guidelines
is that they fail to provide for independent validation of self-
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reported smoking. Although this could be a touchy issue outside
of the laboratory, it seems most unfortunate to prescribe
rigorous standards for data collection and evaluation and yet to
overlook obvious questions concerning the validity of such data.
A minimum step might be to obtain permission of participants to
contact close friends and/or relatives for confirmation of
reported smoking status. Although the accuracy of informant data
is by no means certain, such data would allow at least some
measure of independent validation of self-reports. More
attractive would be the use of biochemical validation, although
admittedly this level of assessment may be problematic outside
the research setting.
Biochemical validation would be appropriate for those
organizations that seek acceptance of their reported outcomes by
the scientific community. Such validation would not be required
for all participants, nor would it be required for all clinics.
A representative sampling of clinics in varying locations should
provide a meaningful estimate of the accuracy of self-reports.
There are laboratories that are equipped to perform biochemical
analyses for outside organizations. The cost of such analyses
would be relatively modest (especially if limited to a random
sample of those participants reporting abstinence at follow-up)
and easily could be defrayed by a small charge for treatment to
all participants. Comments on biochemical validation procedures
are contained elsewhere in this monograph (e.g., Benowitz, this
volume).
BASIC MEASUREMENT ISSUES
At first glance, the assessment of smoking behavior appears to be
a very simple matter. Smoking is readily observable and occurs
in discrete units. But what is the best unit of measurement?
Tallies can be kept of cigarettes, of actual puffs, or of amount
of tar and nicotine ingested (McFall 1978). Furthermore, these
records can be kept on an hourly basis, a daily basis, or even a
monthly basis. Most investigators have emphasized number of
cigarettes smoked per day. As McFall points out, there is
nothing magical about this particular measure. Certainly it
overlooks a great deal of important information. However, it
does have the advantage of providing a common standard of
comparison.
Discussion of assessment issues in smoking has focused primarily
on determining the outcome of structured interventions. Two
fundamental indices have been used: rate, using days as the unit
of time and typically expressed in percentage of baseline
smoking; and abstinence, the number or percentage of subjects
abstaining altogether (Lichtenstein and Danaher 1976). Despite
the fact that abstinence is a nominal scale datum which
necessitates less powerful, nonparametric statistical procedures,
it does have several important advantages over rate. It is less
susceptible to reactivity effects of self-monitoring, less likely
to require transformations in the data due to a marked skewness
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in the distribution of outcome, and it is a better indicator of
clinically significant, as opposed to statistically significant,
treatment effects.
Reactivity is likely when subjects in treatment self-monitor
their smoking rates because of the implicit assumption that these
rates will decrease (Lando 1981). Self-monitored smoking rates
tend to be lower than subjects' prior estimates of their smoking
behavior. Smoking rates are also likely to be susceptible to
changes in self-monitoring procedures. It is obviously desirable
that data collection procedures remain constant. Otherwise,
changes in rate may be partly a reflection of changes in
measurement. On the other hand, the major concern with
abstinence data is not how the self-report data are obtained, but
the possibility that subjects might not be telling the truth.
A crucial issue relates to the selection of a method or methods
of assessment. This issue is addressed by McFall (1978) in a
comprehensive and useful discussion. Possible measures include
self-reports, controlled laboratory observations, unobtrusive
naturalistic measurements, collaborator reports, and correlates
of smoking behavior. Each of these methods has potential
advantages and disadvantages.
The most cons-only used measure has been self-report. The obvious
advantage is that the subject is in a better position than anyone
else to observe his or her own smoking behavior continually.
Unfortunately, there is no assurance that the subject will be
accurate or even honest. False reporting has been documented in
a number of studies. Self-reports can also be reactive, as
noted previously. The fact that many Studies have relied solely
upon unverified self-reports as a measure of outcome is therefore
a cause for concern.
Observing smoking under controlled laboratory conditions is a
more precise method, but it also presents significant problems.
Smoking behavior observed in the laboratory may be quite
different from smoking that occurs under more natural conditions.
Unobtrusive naturalistic measurement presents another
possibility. McFall (1978) suggests the monitoring of samples of
cigarette butts as one example. The butts could be collected in
several locations and would provide both an indirect check upon
self-reported smoking and some indication of within-subject
changes in smoking over time. One of the few studies to use
cigarette butts as a measure of smoking was that of Auger et al.
(1972). Unobtrusive measurement procedures suffer from several
shortcomings, including difficulty, expense, impracticality in
many situations, and potential invasion of privacy.
Collaborator reports have been used increasingly in recent years.
Investigators sometimes ask subjects to provide the names of
close friends or relatives who are in a position to observe their
smoking and can be contacted periodically for reports (cf. Lando
1981). This strategy was recommended both as a check upon self-
reports and as an additional means of locating subjects at
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followup. Again, however, the use of collaborators is no
guarantee of accuracy. Recruitment of friends as observers can
lead to increased reactivity. Cooperation may be very difficult
to obtain, performance many be sloppy, and there may be obvious
bias. Because the collaborators are often close friends of the
subjects, their reports my be no more objective than those of
the subjects themselves. McFall (1978) suggests that the
extremely high correlations often obtained between subjects and
collaborators may be a reflection of collusion more than
accuracy. Because there is no simple means of ascertaining the
validity of collaborator reports, additional checks upon the
accuracy of subjects’ self-reports are highly desirable.
Correlates of smoking behavior are a very promising possibility.
Investigators have attempted to establish valid indirect measures
of smoking for a number of years, and such measures receive
considerable attention in this volume.
QUESTIONNAIRE DESIGN
The American Lung Association intake and followup questionnaires
provide a useful starting point in considering issues of
questionnaire design. They constitute a package that can be
conveniently used by local associations and that allows
collection of appropriate minimal information. A standardized
form such as the American Lung Association intake questionnaire
would represent a substantial improvement over current practice
in that clinics could report a common data set. The American Lung
Association materials are also attractive in their brevity and
ease of administration.
A major difficulty at this point in recommending questionnaire
design is that it is by no means clear what kinds of information
are crucial. Furthermore, questionnaire content my differ
according to the purpose of the user. Researchers may be
interested in issues that are of minimal concern to clinical
practitioners and vice versa. The current paper will not attempt
to specify the final form of a questionnaire for either research
or clinical use. However, suggestions will be drawn from the
literature for types of items that might be included.
Essential information relating to subject characteristics could
prove extremely valuable in comparing smokers who enroll in
various types of programs. Obviously, two treatments each of
which produce 30 percent long-term abstinence my not be
equivalent in effectiveness if smoking history characteristics of
enrollees in the two program are radically different. A
consensus at this point might be that information should be
obtained concerning age, sex, number of years as a smoker,
current daily rate of smoking, previous quit attempts and
duration of abstinence, and brand smoked (NICSH 1974).
Data on occupation, education, and income may also be useful in
characterizing subject samples and in comparing smokers who
enroll in various programs. The vast majority of formal smoking
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cessation treatments have been strongly weighted toward
participation from middle and upper middle socioeconomic strata.
Assessment of socioeconomic indicators is likely to focus
additional attention on the need to reach underserved
populations. It is also possible that systematic differences
exist in the types of participants recruited by various programs.
An obvious example would be that a commercial clinic requiring an
investment of several hundred dollars is extremely unlikely to
enroll subjects from lower class backgrounds.
An important concern is related to inclusion of potential
predictor variables. A minimal questionnaire might be limited to
a few items assessing subject and smoking history
characteristics. Such a questionnaire could be standardized
along the lines of the intake measure construct&i by the American
Lung Association. Researchers (and practitioners) who are
interested in predicting outcome could solicit additional
information.
What are some likely predictor variables? The answer to this
question may be important not only in anticipating probable
outcome, but also in assigning individuals to particular
treatments. Standardized data collection over numerous programs
and a substantial subject pool should provide considerable
information. This in turn might facilitate effective tailoring
of treatments to the needs of the individual.
Predictor variables that have been identified to date are
generally based upon relatively small numbers of subjects. With
this limitation in mind, a number of such variables can be
suggested. Repeated use of a standardized questionnaire
containing these items would allow much more confidence in their
validity. It appears quite likely that certain categories of
items will prove highly related and that factor analyses will
provide more streamlined predictive measures.
Even the minimal information obtained through the American Lung
Association questionnaire should allow some prediction of
outcome. Roth subjects’ age and smoking rates have sometimes
correlated with reduced consumption in previous studies.
Furthermore, number and duration of previous quit attempts appear
to be predictive as well. Supportiveness of others and
prevalence of smoking in home and work environments might also be
important. Other predictor variables contained in the American
Lung Association questionnaire may include subjects’ age, sex,
race, marital status, level of education, and occupation.
Perceived readiness to quit is another questionnaire item that
could correlate significantly with outcome.
The predictive power of the American Lung Association measure
might be improved, however , if on some items subjects were
allowed a greater range of choices. Thus, as one example, rather
than simply indicating whether individuals in the environment are
either supportive or nonsupportive of quit attempts, it might be
more useful to allow subjects to report varying levels of support.
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Many other potential predictor variables have been identified in
the literature. An especially useful indicator might be
perceived ability to resist smoking urges in specific situations.
Condiotte and Lichtenstein (1981) have published a very promising
instrument. Preliminary data suggest clearly that subjects are
quite capable of anticipating situations in which they are likely
to experience difficulty. This type of measure could provide an
important link between assessment and treatment intervention.
Knowledge of circumstances under which subjects are apt to
experience difficulty may facilitate tailoring of treatment
programs to the needs of individual participants. It should be
noted that the Condiotte and Lichtenstein questionnaire is
somewhat lengthy (47 items). Preliminary data suggest that a
substantial reduction in the number of items would be quite
feasible.
A simple eight-item questionnaire developed by Fagerstrom (1978)
to assess physiological correlates and dependence might also be
of considerable interest. Preliminary validity data are
encouraging. It might be especially interesting to assess the
correlations between this paper-and-pencil instrument and both
topographical and biochemical indicators of smoking exposure.
The single item assessing time from awakening to first cigarette
could provide a rough indication of dependency.
Other questions that might be included appear almost infinite.
Several studies have found that negative affect smokers (those
who smoke in response to tension, anger, depression, or other
negative emotions) are less likely to remain abstinent (cf.
Pomerleau et al. 1978). Items indicative of Type A behaviors
(impatience, overwork, competitiveness, aggressiveness) might
also be predictive of unsuccessful outcome. Subjects who are
able to state only limited tangible expected benefits from
quitting may be poor candidates for abstinence.
Life events measures (e.g., what types of stressful circumstances
are present either currently or in the recent past) may correlate
with abstinence. Relevant stressors could include such events as
a recent move, a divorce, a change in job status, or the loss of
a close friend or relative. Attributions for previous
unsuccessful abstinence attempts could also be quite important.
obviously, subjects who attribute a previous failure to a
particular set of conditions should have a plan of attack for
coping with similar conditions in the future. A consideration of
prior withdrawal symptoms may provide an additional indicator of
both expected outcome and of types of problems in remaining
abstinent. A measure published by Shiffman and Jarvik (1976)
contains a number of items that might be used in assessing
withdrawal.
Attention might also focus specifically upon actual relapse
episodes. Issues to be considered might include the course of
relapse, where the episode occurred, and the subject's emotional
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and physical states at the time. Information relating to
presence of other people, interpersonal conflict, social
pressure, stress, and withdrawal symptoms all could be of value
in predicting and preparing for future crisis situations.
Alcohol consumption associated with a relapse could be especially
significant (cf. Marlatt and Gordon 1980; Shiffman 1981).
There are other miscellaneous predictive items suggested by the
literature. For example, use of alcohol and other drugs,
caffeine intake, and participation in psychotherapy may all be
associated with outcome. General health status may be important,
as well as physician advice to quit. Presence of young children
in the home has been identified as another possible factor
related to abstinence. Number of driving accidents has
correlated negatively with outcome. Success in changing another
major personal habit could be a positive indicator.
Current or anticipated pregnancy appears to be an obvious item to
include for female smokers. Information on prior attendance at
formal cessation programs may be important. Concerns with weight
gain could suggest problems in remaining abstinent. Moderate to
high physical activity levels, on the other hand, might be a
positive factor. Subjects’ “want/should” ratio (Marlatt and
Gordon 1980) and perceived pressure from others to quit might be
other important points to consider.
Future Directions
Public service clinics may limit themselves to relatively minimal
intake data provided by questionnaires such as that currently
employed by the American Lung Association. Researchers may adopt
instruments that are considerably more involved. At the level of
both research and clinical application, use of standardized
questionnaires could contribute much to our knowledge.
It would be especially valuable if self-report measures were
shown to correlate with other dimensions including topography and
biochemical exposure. An obvious strategy would be to include
questionnaire items assessing these other dimensions.
Unfortunately, there is little evidence that subjects can
accurately report topography, much less biochemical intake. Even
so, it is possible that a paper-and-pencil measure could provide
a rough indicator of the other dimensions. Future research might
provide a useful formula for estimating topography and biological
exposure from self-report data.
If questionnaire measures can eventually receive son-e validation
at the levels of topography and physiological assessment, an
important element of convergent validation will have been
attained. One strategy might be to train subjects to be better
observers of their own smoking behavior. Frederiksen and his
colleagues (e.g., Frederiksen et al. 1976) have successfully
taught smokers to monitor a number of topographical factors and
even to discriminate differing levels of carton monoxide uptake.
Promising instruments designed to supplement self-report are
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discussed elsewhere in this monograph. Pickens (this volume) has
constructed a device that can measure important components of
smoking topography in the natural environment. Kozlowski and his
colleagues (Kozlowski 1981; Kozlowski et al. 1982) describe an
innovative technique which enables smokers to estimate their
actual tar and nicotine intake by examining the appearance of
spent cigarette filters. All of these methods should contribute
significantly to more precise measurement.
ADDITIONAL ISSUES IN DATA COLLECTION AND CLINIC EVALUATION
The National Center for Health Education guidelines provide a
sound basis for evaluating smoking cessation treatments, as was
discussed previously. These guidelines are not complete,
however, and additional information should be obtained to allow
optimal assessment of interventions. Clinics should routinely
note numbers of smokers who inquire about treatment, as well as
those participants actually attending an initial orientation
session. Requirements for participation also should be those
smokers who make preliminary inquiries or that impose highly
stringent screening criteria could report very high abstinence
rates and yet still be quite limited in generalizability.
Both practitioners and researchers should maintain cumulative
records of all participants in treatment. Maintenance of
cumulative data sets could provide vital information in
evaluating trends in outcome. In the author’s own research,
computer records have been established for all smokers who have
entered treatment during the previous 6 years. The need for
cumulative records is underscored by the fact that it often has
been difficult to secure adequate subject samples for evaluation
of treatments. This problem has been compounded by the use of
group treatment formats in which group process variables
sometimes outweigh specific treatment effects (Lando 1978).
Not only would cumulative data sets be useful in evaluating
overall effectiveness of interventions, they may also serve to
help isolate potential predictor variables (large-scale subject
samples might be of considerable benefit in validating proposed
assessment devices). In addition, this would facilitate analysis
of subject characteristics for purposes of assigning participants
to appropriate treatment conditions. Thus far, most work related
to tailoring interventions to the needs of individual smokers has
been disappointing. This may be due in part to assignment
criteria that are either totally intuitive or that are based upon
very limited subject samples.
Minimal statistical power is lacking in many published studies,
especially when the major criterion is a dichotomous abstinence-
nonabstinence outcome. One means of compensating for
unsatisfactory power in individual studies may be to replicate
promising interventions in successive program. Thus, in the
author’s research, an apparently effective broad-spectrum
treatment encompassing oversmoking and maintenance has become a
standard against which to compare other interventions. It
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thereby has been possible to compute both average effectiveness
and variability in outcome for this method. Results to date with
this broad-spectrum intervention have consistently reached or
slightly exceeded 40 percent abstinence at 12-month followup.
Confidence in the validity and generalizability of these results
is enhanced by numerous replications in both research and public
service settings.
Collection of long-term followup data is obviously essential.
Although a 12-month followup period now appears generally
accepted as a minimum standard, soliciting of additional data
beyond this point is relatively inexpensive and may prove
extremely useful. Subject addresses and telephone numbers
(together with those of informants) should be kept up-to-date.
This should enable contact with a minimum of 90 percent of
initial subjects even after a period of several years (cf. Lando
and McGovern 1982).
Long-term data collection in public service settings might be
facilitated by construction of simple followup assessment kits
containing appropriate questionnaires and a schedule for their
distribution (it was previously recommended that an attractive
and convenient intake measure be developed for public service
use. Ideally, this measure could be self-scoring to increase
subjects' interest.) Such a followup assessment kit could
substantially increase the likelihood of adequate data being
reported by public service programs. In addition to followup
questionnaires, the kits would contain detailed instructions for
contacting nonrespondents.
Long-term followups could address several key questions that have
received little attention. One issue might be the subsequent
smoking history of subjects who fail to achieve abstinence in
cessation programs. Might such participants be more resistant to
subsequent change attempts? Is it possible that future smoking
history for nonabstinent subjects could differ systematically as
a function of the initial treatment? At this point, we simply do
not know. Two programs could conceivably achieve identical
short-term outcomes and yet differ dramatically in later
abstinence attempts initiated by unsuccessful participants.
Schachter (1982) has argued that cumulative success rates are
high both for people desiring to lose weight and to quit smoking.
If the net effect of a treatment is to discourage future
abstinence efforts for the majority of participants, the value of
that treatment must be subject to serious question. This may be
a particular concern for programs reporting 10 to 20 percent 12-
month abstinence. Conceivably, these programs could produce a
negative overall impact. Long-term followup assessment should
focus not only on incidence of smoking but also upon change
attempts among nonabstinent participants. Paradoxically,
treatments that are viewed most favorably could be more likely to
discourage further quit &tempts on the part of continuing
smokers who come to view themselves as confirmed failures.
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Self-efficacy measures (Bandura 1977; Condiotte and Lichtenstein
1981) might also be useful at followup as well as during
treatment. Such measures could be informative both in camparing
clinics and in predicting subsequent (successful) abstinence
attempts. Clinics that place their sole emphasis upon abstinence
may risk greater reductions in self-efficacy among nonabstinent
participants than do clinics that appear to allow for
intermediate results. In this context, it is possible that
nicotine fading procedures may be recommended even if research
definitively indicates that switching to low tar and nicotine
cigarettes is ineffective in reducing risk. Nonabstinent
nicotine fading subjects may see themselves as having achieved
tangible progress in overcoming their smoking habit. This
perception might in turn predict future efforts to abstain (of
course, the reverse is also possible: nonabstinent participants
may be more prone simply to continue what they perceive to be a
safer style of smoking).
In addition to collecting data on subsequent smoking history and
self-efficacy, investigators might do well to monitor relapse
episodes in subjects who achieve initial abstinence. Such
monitoring could improve understanding of major risk factors.
This improved understanding could in turn facilitate the
development of stronger inoculation strategies. Of particular
interest might be any reported coping strategies by subjects who
are successful in dealing with stressful situations and by those
who are unsuccessful.
CONCLUSIONS AND ADDITIONAL RECOMMENDATIONS
Bernstein (1978) has argued that service providers as well as
researchers should see careful data collection and description of
treatment techniques as a fundamental part of their
responsibility. Lichtenstein (personal communication) has
suggested that interventions be required to meet specific
standards for accreditation. This possibility may merit further
attention. In the meantime, better dissemination of existing
standards for evaluating treatments (e.g., definitions of long-
term abstinence rates) might be of value in helping the general
public to make more informed choices among available treatment
programs. Unfortunately, although several major providers have
endorsed the NCHE guidelines, it is not generally clear that they
are following these guidelines in practice.
If both practitioners and researchers adopt certain standardized
practices in data collection and questionnaire design, it may
even be possible to pool data sets for purposes of some analyses.
Perhaps the Office on Smoking and Health or some other central
resource could serve as a depository or referral source for data
that meet specific guidelines. These data sets would be
available to researchers and would provide a much larger
cumulative subject pool than would otherwise be possible. The
requirement that guidelines be met for inclusion of data might
serve as a further incentive to adhere to rigorous standards.
These data Sets could represent a rich archival source for
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investigators in dealing with such issues as isolation of
predictor variables and tailoring of treatment to invidual
smokers.
An obvious starting point would be to adopt a standardized
minimal intake questionnaire. The questionnaire could be
developed along the lines of that currently used by the American
Lung Association (again, this would in no way preclude collection
of additional information). The adoption of a questionnaire,
together with adherence to NCHE guidelines in tabulating and
reporting outcome, would provide considerable information. It
would be possible to compare characteristics of smokers who tend
to enroll in various types of interventions. It would also be
possible to achieve much more meaningful comparisons of outcomes
for different treatments.
Numerous suggestions have been presented for data collection and
questionnaire design. These suggestions should be considered in
the context of procedures discussed elsewhere in this volume for
both topographical and physiological assessment. It now appears
possible to achieve relatively sophisticated assessment of
smoking patterns at fairly minimal cost. Inexpensive and
unobtrusive monitoring devices have been described that are
capable of measuring tobacco intake in the natural environment.
Precise laboratory procedures are available for observation of
smoking topography. These procedures can be supplemented by
training subjects to be much more sensitive observers of their
own smoking in the natural environment.
Future questionnaires are likely to be considerably more
sophisticated than those currently available. Self-report items
may provide information relevant to dimensions of both topography
and physiological exposure. A combination of self-report,
topographical, and physiological indices might allow more
accurate estimation of the extent to which individual smokers are
“at risk.” Such information potentially could be used by smokers
who are either unable or unwilling to abstain in achieving
clinically significant reductions in exposure. As noted above,
accurate guidelines for defining categories of smokers (e.g.,
“light smoker,” “moderate smoker,” “heavy smoker”) must consider
far more than just average number of cigarettes smoked per day.
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Evaluation of Smoking Risk: Some
Proposed Minimum Standards
Lee W. Frederiksen, Ph.D.
The topic of this paper is the assessment of smoking in
organizational settings. While the assessment of smoking in such
settings (e.g., worksite) is not fundamentally different from
assessment in other settings (e.g., treatment clinics or
classrooms), this perspective, as well as the special
characteristics of the research environment, serves as the
background for discussion.
This discussion will concentrate on minimum standards. What are
the requirements on the smoking researcher, if he or she wants to
meet minimum scientific standards of acceptability? Development of
innovative programs does not necessarily require extensive
measurement considerations initially, but if replicable and
reliable efforts are to be undertaken, minimum standards are
clearly desirable.
Assessment in organizational settings is primarily concerned with
reduction of health risks. This concern often, but not always,
translates into some level of smoking cessation. These are similar
concerns to those existing in any treatment situation. whether it
be a hospital clinic, a classroom, or a self-help project.
These concerns are, however, somewhat different from those of
researchers interested strictly in a laboratory analysis of
behavior and pertinent physiological and pharmacological research.
Some of the standards that are appropriate in treatment
interventions are not necessarily appropriate for all laboratory
studies. However, it is clear that a variety of measures developed
in the laboratory should be applied in the natural environment.
ASSUMPTIONS
Two fundamental assumptions provide starting points for developing
minimal standards for assessment/evaluation. One of those starting
points involves the issue of why we are interested in smoking
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behavior. The other assumption is that the reason for scientific
study of smoking behavior is the potential health risk related to
tobacco use. This is contrasted to a view that would characterize
smoking as wrong on moral, political, religious, or any other
grounds. In short, in the organizational setting the primary
criterion is smoking risk and not smoking behavior per se.
As has been stated by a number of researchers, the reason for their
initial interest in smoking behavior is that it was a behavior
consisting of a simple, innocuous response for which a frequency
measure was appropriate. Smoking is, of course, an interesting
behavior from a whole range of perspectives, but in the
organizational setting the concern must be with both the behavior
and the associated health and safety risks. There are design and
analysis implications when it comes to measurement criteria and the
significance of research outcomes in organizational settings.
Those who are involved in risk reduction and smoking cessation in
organizational settings have taken a view that emphasizes this
aspect of the issue. An example of the level and areas of concern
may be useful: Individual A has never used tobacco products in any
form. Individual B has a long history of smoking; he has smoked
one cigar a week for 20 years (after Sunday dinner) which was not
inhaled. Individual C is also a smoker, consuming 2 1/2 packs of
high tar, high nicotine, high CO cigarettes each day. From a
smoking versus nonsmoking distinction, Individual A is clearly
different from Individuals B and C. However, from a purely health
risk standpoint, it is likely that A and B are more similar and
markedly different from Individual C. It is clear that simple
binary distinctions between smoking and nonsmoking do not capture
the full range of risk and are consequently of little value by
themselves.
The second starting point is our view of smoking behavior. In
times past, many of us working in smoking research tended to view
it as a relatively simple, straightforward behavior: either the
individual smoked or didn't smoke. Smoking rate (number of
cigarettes per unit time) was considered to be an adequate
descriptor of smoking behavior. A few investigators did examine
and discuss the substance used; however, even this was extremely
rare (cf. Frederiksen et al. 1979).
In recent years, it has become increasingly clear that this is a
far too simplistic picture. Considerable variation exists among
long been assumed that situational factors could affect smoking
products and the manner in which they are consumed. While it has
rate, the evidence of recent years has also demonstrated that
smoking topography can be affected by a host of variables such as
physical characteristics of the cigarette, perhaps pharmacological
interaction with other substances such as alcohol and coffee,
cigarette deprivation, social factors, and instruction given to the
smoker (cf. Frederiksen et al. 1981). The picture that has emerged
is of a complex multiply determined behavior sensitive to a variety
of environmental and pharmacological variables.
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Overall it becomes apparent that while our concern is "risk," an
adequate description of smoking must involve the assessment of what
is smoked, the rate or temporal pattern of that consumption, and
smoking topography (puff rate, puff size, interpuff interval, puff
volume, etc.) (Frederiksen et al. 1979; Frederiksen and Martin
1979). While details of this argument are not reviewed here, it
has received some recent empirical support. In a recent study,
designed to predict alveolar carbon monoxide levels, it was found
that the best predictor was a combination of three variables.
Using a stepwise multiple regression procedure, the predictors
(accounting for 36% of the total variance) included one
topographical variable (interpuff interval), one variable
describing substance smoked (carbon monoxide yield), and one
variable describing smoking rate (Burling et al. 1983).
It is apparent that we have delineated numerous specific variables
which might provide an adequate description of smoking behavior.
However, no single variable provides an adequate description. The
interrelationships among the variables are not clear. Further, we
do not understand all the factors affecting any particular
variable. This suggests a need for caution and puts a premium on
comprehensive assessment under known, standardized conditions.
With this background, minimum standards for the adequate assessment
of smoking behavior in organizational settings can be examined.
MINIMUM STANDARDS OF MEASUREMENT
Basic standards of scientific research must be applied to
laboratory, treatment, and prevention efforts regardless of the
setting in which they are implemented. Thus, for example, in
organizational settings it is essential that the methods used for
assessment of smoking behavior be held constant across experimental
conditions. The rationale for this view is fairly evident. Since
different smoking assessment procedures have been demonstrated to
be differentially reliable and yield different results (e.g.,
Frederiksen et al. 1975), it behooves the investigator to hold them
constant across assessment. This point may be sufficiently
obvious, but investigators do not adhere to this simple
requirement. It is not uncommon for some reports to include
retrospective baselines or self-monitored smoking rates during
baseline and treatment conditions, with telephone followup on the
proportion of smokers abstinent (Frederiksen et al. 1979). Clearly
these are not directly comparable measures. If the investigators
are changing measures from phase to phase, they are systematically
biasing their data across conditions.
Another issue of importance is that there should be some analysis
of measurement reliability at each assessment point. Here, again,
the rationale seems simple and straightforward. Yet, with
surprising frequency, studies make no attempt to validate a
smoker's self-report. While historically there may have been
practical reasons making such validation difficult, the advent of
biochemical measures seems to have made such validation more simple.
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In a review of treatment and behavioral research studies
(Frederiksen et al. 1979), it was noted that only 20 percent of the
studies reviewed took measurement reliability at more than one
point. For example, measurement reliability might only be
undertaken during followup. or only during baseline, but not
regularly and consistently throughout the study. Given the
inherent method variance in smoking measurement, changing measures
in mid-study necessarily provides distorted and essentially
unusable data.
Techniques presented by investigators in other chapters In this
volume describe useful, reliable, and important tools for obtaining
information which will assist in changing tobacco use behavior and
yield concomitant reductions in risk. Thus, for example, given the
ready availability of carbon monoxide measurement! reliability
assessments from a confederate, or automatic smoking machines, it
seems incomprehensible that reliability checks should not be
conducted at each assessment period.
A basic requirement is that data should be reported to identify the
proportion of individuals who are currently not smoking. Not
smoking is defined as a smoking rate of zero for a specified period
of time (probably a minimum of one week). Further, the length of
time that individuals have not been smoking should also be
determined. This recommendation recognizes abstinence as total
absence of smoking behavior over a specified period of time. It
reflects the common practice of lumping smokers with nonsmokers to
get an "average smoking rate" and also suggests that there be a
minimum time of nonsmoking to be calculated as abstinence.
It is relatively clear that smoking is a continuum. A person who
smokes two and a half packs of high-nicotine/high-tar cigarettes is
not the same as someone who smokes three low-nicotine/low-tar
cigarettes a week. These behaviors constitute different patterns
with different levels of risk. However, it appears obvious that at
some point on that continuum the smoker moves over into a different
kind of category, and that is total abstinence. Therefore it is
tremendously important that at the point of abstinence the
individuals be examined separately. Shifts in data emerge for
subjects as a function of individual behavioral change, but these
data may not be reflected in group data. Thus the goal is to track
individual patterns, not aggregate percentages.
Finally, total abstinence is meant to be total. Some investigators
have used abstinence criteria of less than one cigarette in a week
or less than one in a month. It is suggested that the best course
for use is to set a minimum period of time (for example, at least
one week) and if the person is not smoking at all they are
abstinent at that point. In any case, the length of time that is
used for abstinence criteria must be specified. It should, of
course, be noted that the "one week" requirement is indeed a
minimum standard and should not be associated with sustained
abstinence.
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An essential measurement issue is that data for current smokers
should be presented in a way that allows for a determination of
smoking rate (episodes per unit time) and the substance used
(cigarette brand, etc.). This recommendation is to indicate the
minimum level of data. These data should not be presented as an
index that obscures the independent determination of these two
variables, although such an index could be presented in addition to
the individualized variables. It is not immediately apparent that
there is a need to further standardize the time interval over which
rate should be determined nor what data should be presented about
the substance. However, as more data are collected in various
research efforts it may become clear that considerable refinement
is necessary.
In a review of published smoking research, Frederiksen et al.
(1979) found only 20 percent of the studies were sufficiently
detailed to permit determination of not only the rate at which
people were smoking, but also what tobacco products they were
smoking. While it is becoming more common for investigators to
report these data, they are, unfortunately, often reported as an
index. For example the cigarette pack yield of tar or nicotine or
carbon monoxide is multiplied by the average rate to produce
indices. The disadvantage is that it is not clear what these
indices represent.
Further research is also required to permit precise specification
of the time periods over which rates should be integrated. That
is, it is necessary to determine whether the time base for rate
measures should be hourly, daily, weekly, etc. Similarly the
minimum number of units necessary for calculation of rate, i.e.,
how long the behavior should be recorded, is not readily apparent.
Continued effort in delineating the measurement parameters is
essential, and a precise statement on this dimension at present is
impractical.
An important issue is that, whenever possible, a description of
current smokers should also include an assessment of smoking
topography. Here again, it is not possible to specify exactly
under which conditions topography assessment should be made or
which topographical variables should be recorded (cf. Ossip-Klein
et al. 198 ).3 Experimental study is essential, but at this point
it is evident that at least some topographical variables should be
assessed. Further these should be presented in a way that allows
for the separation of topography from the variables of rate and
substance. While the topography may also be combined with these
other variables into an index, the measures should, when reported,
be separable so that comparison with other studies is feasible.
COMMENT
It is suspected that these suggested criteria may be unsatisfying
to some, since they don't clearly delineate categories of smokers
and do not provide closure on which specific measures to use.
Rather, they put an emphasis on two points. One is the quality of
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the data that we are collecting on smoking cessation. Are there
reliable, consistent data that that can be interpreted, broken
down, separated out, and looked at in other ways? In many cases it
is evident that the data are not reliable. and improvement in this
area is essential. Researchers, clinicians, or health educators
must comply with the minimum requirements of measurement. The
second point concerns the detail of the information. It should be
obvious that an aggregate smoking and nonsmoking distinction is far
too gross, as is smoking rate or simple reports of substance
smoked. Therefore the essential element is a need for more
detailed analysis or more detail in analysis. The extent to which
this occurs will determine the extent to which treatment efforts
will move forward.
Despite the critical comments contained herein, there is an
optimistic note in this proposal. That is, it does give us a
criterion or a direction in which to look if clear and comparable
measures of smoking are to evolve.
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Survey and Evaluation Methods:
Smoking Prevention Among
Children and Adolescents
Steven Paul Schinke, Ph.D., and Lewayne D. Gilchrist, Ph.D.
There has in recent years been a marked increase in survey and
evaluative research on tobacco smoking among children and
adolescents in the United States. Scientists and lay persons alike
may wonder why these populations are of interest since children and
adolescents are not supposed to smoke tobacco. Youths under the
age of 16 are ostensibly banned from buying tobacco products nearly
everywhere. Yet never before have so many children and adolescents
smoked cigarettes; and the average age at which they begin gets
younger each year (United States Public Health Service, 1982). The
main reason for studying youths in regard to tobacco use is that
even during childhood girls and boys experiment with cigarettes.
Worse yet and adding grist to the cause for smoking-related survey
and evaluative research is that experimental adolescent smokers
grow up to be tobacco-dependent individuals (Lichtenstein and Brown
1980). As such, young persons risk the disease consequences
associated with long-term tobacco use. Another just as disquieting
reason for studying children and adolescents is that tobacco
smoking has immediate and untoward physical consequences for young
people per se. All these reasons are valid and equally compelling
stimuli for empirical research with youthful populations at risk
for tobacco smoking.
Still, and in spite of a growing body of data, exactly what
constitutes smoking or "being a smoker" during childhood and
adolescence is unclear. The vagaries of youth together with
impediments to assessing this socially disapproved act yield
several definitions of tobacco use. A chapter on tobacco smoking
among children and adolescents in the 1979 Surgeon General's Report
notes, "Such terms as 'regular smoker,' 'occasional smoker,'
'experimental smoker,' and 'nonsmoker' vary from one study to the
next" (Evans et al. 1979, p. 7). The lack of correspondence
between studies is exacerbated by ill-defined criteria for placing
youth in each category of tobacco use. Many reports do not
operationalize and specify the labels used (O'Rourke 1980). Common
and uniform definitions of tobacco consumption categories are
needed.
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Studying children and adolescents with respect to tobacco use is a
formidable task. Childhood and especially adolescence in America
are not well demarked. Societal sanctions against precocious
tobacco use cause young persons to engage in patterns of smoking
that greatly differ from adult usage. For adolescents, more than
for older cohorts in this country, smoking may for some groups
represent a "rite de passage." The practice gets confused with
values that have nothing to do with tobacco dependence. Finally,
girls and boys show wide variability in attitudes and practices
involving tobacco.
This paper considers such issues in conducting tobacco use surveys
and in evaluating smoking prevention and intervention research with
American youth. The authors review what is known about the
peculiarities of nonadults who smoke. They compare and contrast
methods to determine tobacco consumption among members of the
target age groups. These tasks are accomplished in three major
sections. The following sections cover issues of defining
childhood and adolescence, disparate smoking patterns, and
weaknesses of self-reported data. Discussion of each issue
includes recommendations for future surveys and evaluations of
young persons' smoking. Taken as a whole, these recommendations
should provide direction toward more precise and homogeneous
research on tobacco smoking among American children and adolescents
and, of particular importance, provide comparability of results
across research reports.
DEFINING CHILDHOOD AND ADOLESCENCE
The first issue faced in survey and evaluative research with
children and adolescents is defining the age group to study. Who
is a child? Common and anecdotal definitions of childhood are
fairly in agreement that children are small and infantile people,
primarily dependent on adults. Indeed, legal terminology calls
anyone under the age of majority--18 to 21 years in most regions--a
child since she or he is still under her or his parents' care and
responsibility (Gilchrist and Schinke, in press). A theoretical
treatise on child development lately indicated the generic notion
of childhood as not helpful for research purposes. Irving Sigel, a
developmental psychologist, observed a "growing trend toward
eschewing the term child, which is an age-based concept" (1980, p.
348) The present authors concur. Childhood is best expressed as
a developmental epoch, such as might be identified with school
grade.
Deciding who is an adolescent in the United States is more
difficult. Elsewhere the authors suggest adolescence ought not be
equated with "teenage" (Schinke 1981; Schinke and Gilchrist, in
press-b). Physiological, social, and psychological changes
occurring in the transition from childhood to adulthood far exceed
the 13th and 19th years. Again. school grade is a more reliable
indicator of developmental maturity than age (Radius et al. 1980;
Revill and Drury 19801. The developmental literature (Flavell
1977; Greenberg& et al. 1975; Mussen et al. 1979) depicts
adolescence as three stages: early adolescence (school grades 6
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through 8), middle adolescence (school grades 9 through 12), and
late adolescence (college and employment). Smoking behavior at
each stage differs. Surveys document that off-and-on
experimentation is characteristic of early adolescence (Pederson et
al. 1981). Habitual smoking does not typically emerge until middle
adolescence (Evans 1976). Late adolescent smokers are not unlike
adults (Bosse et al. 1980).
An overview of the literature and the work of the authors suggest
that for tobacco smoking research, childhood should be defined as
beginning with birth and extending until a point prior to middle
school, generally through the end of fifth grade. Examples of
contemporary tobacco smoking research with such populations would
be the examinations of the effects of ambient or sidestream smoke
on preschool children who spend considerable time with their
parents.
Another example would be primary prevention research with school
children before the high-risk middle-school years. Regarding
research on adolescent tobacco smoking, young people beyond high
school should be considered adults. Younger subjects are best
described in terms of school grade. Cognitive and behavioral
capacities that differentiate early adolescence from middle
adolescence warrant consideration when designing surveys and
evaluations aimed at American youth.
DISPARATE SMOKING PATTERNS
Because of negative social sanctions on smoking and because
children and adolescents in this country have limited access to
cigarettes, youthful smoking patterns are uneven. Among
fifth-grade children and eighth-grade adolescents. the authors have
learned that many youths will smoke eight to ten cigarettes in an
evening, then not smoke again for several days running (Schinke and
Gilchrist, in press-a). Some adolescents will smoke two packs a
week, with the bulk of cigarettes consumed during 24 to 36 hours
over the weekend. Can these youths be defined in the same way as
young people who smoke a consistent four or five cigarettes a day?
One approach to the question is to examine the physiological
consequences of each consumption pattern. At present, little
research has been done on the consequences or the disease risk
associated with disparate patterns of tobacco use among children
and adolescents (Office on Smoking and Health 1982).
Clearly, more investigations need to examine the physiological
implications of massed doses of tobacco smoking on young people's
still maturing bodies (Frederiksen and Martin 1979). An impediment
to such work is that the topography of tobacco use widely differs
between adults and nonadults. Standard topographical analyses for
adult smokers are: number of puffs per cigarette, puff duration,
length of time from first puff to last, total intake volume, ratio
of intake volume to number of puffs, and interpuff interval
(Epstein et al. 1981). Whether or not children and adolescent
smokers inhale as deeply as and frequently as adult smokers is not
known. If regularity is used to distinguish smokers from
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experimenters, a problem arises. Presumably, youths who smoke
without inhaling suffer fewer physiological consequences than those
who smoke more sporadically but inhale deepy. Some analogues can
be derived from research with adult populations, but the
generalizability of such findings is limited.
For children and adolescents more than for adults, demographic
factors influence smoking habits and tobacco consumption.
Variations in the tobacco smoking of youthful subgroups and
cultures necessitate highly specific samples (Clausen 1968). The
smoker's gender warrants special consideration. Nationally,
cigarette consumption has risen among young women while decreasing
among young men (Bachman et al. 1981). Ethnicity too affects
childhood and adolescent tobacco use. Hunter et al. (1980) found
white 16- to 17-year-olds smoked twice as much as black youths the
same age. Geographic differences also come into play. As an
example, Hunter et al. (1980) learned that one in four adolescent
subjects in southern Louisiana reported regular tobacco chewing.
In all likelihood, these youths would be expected to evidence
spuriously low rates of tobacco smoking when compared with youths
from areas where tobacco chewing is uncommon.
Several approaches may be taken to resolving problems of analysis
which reside in differences emanating from the sources and factors
mentioned above. Less weight should be given to the quantity
(i.e., absolute number) of cigarettes young people smoke. Instead,
more attention ought to be put on the timing and situational
patterns of youths' tobacco consumption. Researchers must a priori
sketch the features that clearly identify their child and
adolescent subject samples. Every report that springs from
research with nonadults ought to carefully delimit the generality
of findings on what was perhaps a sui generic sample of young
persons. Key descriptive features that should be detailed are the
youths' developmental profiles in terms of their cognitive and
physical maturation and their racial characteristics and family
backgrounds.
Investigators should grow acquainted with previous research done
with their youthful sample. Earlier surveys and interventive
programs may dramatically skew children's and adolescents'
responses to current assessments and evaluative research (Glasgow
et al. 1981). Effects of attention, placebo, and experimenter
expectancy are particularly acute with children and adolescents
(Schinke et al. in press). Taking into account the idiosyncracies
of every youthful sample demands extra care. Far from burdensome,
such preliminary steps have manifold payoffs by focusing subsequent
research and by controlling factors which may confound the external
validity of whatever results from the research.
WEAKNESSES OF SELF-REPORT
The bulk of survey and evaluative investigations with children and
adolescents have exclusively relied on self-reported tobacco use
and abstinence. Lack of honesty, poor recall, and desirable
response bias, however, plague self-reports and can yield inchoate
data. The flaws of self-reported smoking are magnified with
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children and adolescents. O'Rourke (1980) speaks to the issue:
"In the light of the possible negative implications to individuals,
especially to youth by their parents, different studies using
similar groups may find different rates of smoking behavior but
which may, in fact, be a function of how well the confidentiality
of the respondent was protected" (p. 163).
Fear of discovery is not the only trouble with self-reports of
children's and adolescents' smoking. For largely developmental
reasons, young people may not know how to classify their own
smoking behavior. As an illustration, self-report criteria from
Pederson et al. (1981) in research with fourth and sixth graders
would have been inadequate for fifth and sixth graders in the
present investigators' sample. Pederson et al. considered their
respondents "regular smokers" if the young persons said they
"usually" smoked cigarettes "just about every day." Youths were
called "occasional smokers" if they reported smoking cigarettes
"once in a while but not every day" (Pederson et al. 1981, p.
143). Qualifiers of "usually," "just about," and "once in a while"
permit too much leeway for children and adolescents who must relate
the terms to their own behavior. Youths under age 15 are
vulnerable to misinterpreting imprecise language (Duke et al.
1980). Cognitive operations of abstract thinking are generally not
mastered until late adolescence (Gilchrist 1981). Before that
time, young people have difficulty pairing overt actions with
symbolic words. Moreover, children's and adolescents' ability to
recall patterns of recent behavior is notoriously poor (Schinke et
al., in press-b).
To better separate indistinct categories of tobacco use,
researchers have lumped young persons into fewer, self-defined
groups. Thirteen- to 17-year-olds in a national household survey
done by Yankelovich et al. (1977) were thus grossly grouped as
smokers or nonsmokers regardless of patterns of cigarette use.
Lotecka et al. (1981) asked high school students "to identify
themselves as a Smoker, Non-Smoker, or Ex-Smoker" (p. 524). Not
surprisingly, the team found their third group to be quite
heterogeneous and noted, "The definitions with Ex-smokers (sic)
were blurred at times with some individuals unsure about their
status" (Lotecka et al. 1981, p. 524).
For the sake of unified and compatible research on childhood and
adolescent tobacco smoking, objective definitions are needed. The
definitions ought to be specific enough for direct translation into
survey and evaluation protocols. Definitions of youthful smoking
must nonetheless apply to diverse and varied research on the
incidence, effects, concomitants, prevention, and cessation of
tobacco use among children and adolescents. These ends can be
served neither by simple bipolar categories nor by elaborate
nosologies of youths' tobacco smoking. Rather, researchers must
strike a balance between the two poles.
In search of a harmonious yet broadly applicable definition of
tobacco use by children and adolescents, the authors drew from the
literature and from their own evaluative research. Most
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influential were definitions from the Bogalusa Heart Study (Hunter
et al. 1980) and those from the authors' primary prevention efforts
with fifth- and sixth-grade boys and girls (Schinke and Gilchrist,
in press-a; Schinke et al., in press). Combined, the young samples
from these projects total about 3,500 8- to 17-year-olds of both
sexes. Definitions produced by interdigitation of the survey and
evaluative research cover seven nonexlusive categories of youthful
tobacco smoking. These are:
Nonsmoker. A child or an adolescent who has never intentionally
puffed on a cigarette.
Experimenter. A child or an adolescent who on at least one
occasion but less then once weekly during the most recent month
lit, held, puffed, or inhaled any form of tobacco.
Ex-experimenter. A child or an adolescent experimenter in a prior
month who did not intentionally puff on any form of tobacco in the
most recent month.
Adopter. A child or an adolescent who once or more a week during
the most recent month intentionally inhaled tobacco smoke.
Increased adopter. An adopter who previously smoked less often
than during the most recent month.
Decreased adopter. An adopter who previously smoked more often
than during the most recent month.
Ex-adopter. An adopter in a prior month who has not lit, held,
puffed, or inhaled any form of tobacco in the most recent month.
Figure 1 lays out a schematic presentation of these definitional
categories plotted across the life span with respect to tobacco
consumption and disease risk.
The seven categories defined above offer distinct advantages to
tobacco smoking research with children and adolescents. The
definitions are responsive to any youthful age group and tobacco
substance. They permit investigators to move young persons from
one category to another as their smoking behavior shifts. The
categories can be assigned on the basis of self-reported,
observational, and biochemical data. As depicted in figure 1, the
definitions have implications for theory building. The graphed
categories reveal how young people maintain, decrease, and increase
one facet of cancer disease risk by altering their tobacco use.
The definitions allow survey and evaluative researchers to specify
and delineate a homogenous study sample. In all likelihood such
homogeneity will make data gathering more focused and will presage
improved surveys, prevention programs, and treatment efforts.
Last, the seven inclusive definitions will foster better
communications among smoking investigators. When a number of
scientists adopt the seven groupings of childhood and adolescent
tobacco users and nonusers, normative data can be amassed and
exchanged.
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FIGURE 1. Schematic presentation of seven categorical definitions of children and
adolescent tobacco users and nonusers.
SUMMARY
Past behavioral research on the special characteristics of tobacco
smoking among children and adolescents is fraught with definitional
ambiguities. More precise benchmarks of these age groups will
facilitate mutually advantageous investigations. Researchers ought
to agree on their target age cohorts. Too, investigators should
account for the peculiar tobacco smoking patterns of children and
adolescents who are research subjects. Finally, researchers should
reach a consensus on how they categorize various kinds of young
nonsmokers, smokers, and exsmokers. Recommendations put forth here
are an attempt toward common parameters for researching tobacco use
among American children and adolescents.
REFERENCES
Bachman, J.G.; Johnston, L.D.; and O'Malley, P.M. Smoking,
drinking, and drug use among American high school students:
Correlates and trends, 197511979. Amer J Public Health, 71,
59-69, 1981.
Bosse, R.; Garvey, A.J.; and Glynn, R.J. Age and addiction to
smoking. Addictive Behaviors, 5, 341-351, 1980.
Clausen, J.A. Adolescent antecedents of cigarette smoking: Data
from the Oakland growth study. Social Science and Medicine,
1, 357-382, 1968.
Duke, P.M.; Litt, I.F.; and Gross, R.T. Adolescents' self-
assessment of sexual maturation. Pediatrics, 66, 918-920, 1980.
Epstein, L.H.; Ossip, D.G.; Coleman, D.; Hughes, J.; and Wiist, W.
Measurement of smoking totography during withdrawal or
deprivation. Behavior Therapy, 12, 507-519, 1981.
Evans, R.I. Smoking in children: Developing a social
psychological strategy of deterrence. Preventive Medicine,
5, 122-127, 1976.
Evans, R.I.; Henderson, A.; Hill, P.; and Raines, B. Smoking in
children and adolescents. In U.S. Department of Health,
Education, and Welfare, Public Health Service, Smoking and
Health: A Report of the Surgeon General. Washington, D.C.:
U.S. Government Printing Office. 1979.
Flavell, J.H. Cognitive Development. Englewood Cliffs, N.J.:
Prentice-Hall. 1917.
Frederiksen, L.W:, and Martin, J.E. Carbon monoxide and smoking
behavior. Addictive Behaviors, 4, 21-30, 1979.
Gilchrist, L.D. Social competence in adolescence. In S.P. Schinke
(Ed.), Behavioral Methods in Social Welfare. New York: Aldine,
1981.
Gilchrist, L.D., and Schinke, S.P. Counseling with adolescents
about their sexuality. In C.S. Chilman (Ed.), Adolescent
Sexuality in a Changing American Society. New York: Wiley, in
press.
Glasgow, R.E.; McCaul, K.D.; Freeborn, V.B.; and O'Neill, K.
Immediate and long term health consequences information in the
prevention of adolescent smoking. Behavior Therapist, 4, 15-16,
1981.
103
Greenberger, E.; Josselson, R.; Knerr, C.; and Knerr, B. The
measurement and structure of psychosocial maturity. J Youth
and Adolescence, 4, 127-143, 1975.
Hunter, S.M.; Webber, L.S.; and Berenson, G.S. Cigarette smoking
and tobacco usage behavior in children and adolescents:
Bogalusa Heart Study. Preventive Medicine, 9, 701-712, 1980.
Lichtenstein, E., and Brown, R.A. Smoking cessation methods:
Review and recommendations. In W.R. Miller (Ed.), The
Addictive Behaviors: Treatment of Alcoholism, Drug Abuse,
Smoking, and Obesity. New York: Pergamon, 1980
Lotecka, L., and Lassleben, M. The high school "smoker": A field
study of cigarette-related cognitions and social perceptions.
Adolescence, 16, 513-526, 1981.
Mussen, P.H.; Conger, J.J.; Kagan, J.; and Geiwitz, J.
Psychological Development: A Life-Span Approach. New York:
Harper & Row, 1979.
O'Rourke, T.W. Methodological considerations to improve
anti-smoking research. J Drug Education, 10, 159-171, 1980.
Pederson. L.L.; Baskerville, J.C.; and Lefcoe, N.M. Multivariate
prediction of cigarette smoking among children in grades six,
seven and eight. J Drug Education, 11, 191-203, 1981.
Pederson, L.L.; Stennett R.G; and Lefcoe, N.M. The effects of a
smoking education program on the behavior, knowledge and
attitudes of children in grades 4 and 6. J Drug Education, 11,
141-149, 1981.
Radius, S.M.; Dielman, T.E.; Becker, M.H.; Rosenstock, I.; and
Horvath, W.J. Health beliefs of the school-aged child and their
relationship to risk-taking behaviours. International J Health
Education, 23(4), 3-11, 1980.
Revill J and Drury, C.G. An assessment of the incidence of
cigarette smoking in fourth year school children and the factors
leading to its establishment. Public Health, 94, 243-260, 1980.
Schinke, S.P., and Gilchrist, L.D. Primary prevention of tobacco
smoking. J School Health, in press-a.
Schinke, S.P., and Gilchrist, L.D. Teaching Adolescents Life
Skills. Baltimore:
Schinke, S.P.;
University Park Press, in press-b.
Gilchrist, L.D.; Lodish, D.; and Bobo, J.K.
Strategies for prevention research in service environments.
Evaluation Review, in press.
Sigel I.E.
in the 1980's:
Child development research in learning and cognition
Continuities and discontinuities from the
1970s. Merrill-Palmer Quarterly, 27, 347-371, 1981.
United States Public Health Service, Department of Health and Human
Services. Health Consequences of Smoking--Cancer: A Report of
the Surgeon General (Publication No. 82-50179). Washington,
D.C.: U.S. Government Printing Office, 1982
Yankelovich, Skelly & White, Inc. Cigarette Smoking Among
Teen-Agers and Young Women: Summary of the Findings (DHEW
Publication No. (NIH) 77-1203). Washington. D.C.: Department
of Health, Education, and Welfare, Public Health Service,
National Institutes of Health, National Cancer Institute, 1977.
104
Issues in the Measurement
of Smoking: Summary and
Discussion
Edward Lichtenstein, Ph.D., John Grabowski, Ph.D., and
Catherine S. Bell, M.S.
Investigators were attracted to the experimental analysis of
smoking behavior for diverse reasons. The perceived simplicity of
measurement appealed to some clinical investigators who had been
dealing with less quantifiable phenomena. For others, smoking
behavior and related or pharmacological issues provided a logical
area for examination of related problems. From a clinical
perspective, the goal was to eliminate or reduce tobacco use, and
it appeared that the behavior could be measured by simply asking
smokers how many cigarettes they smoked per day. Other scientists
and clinicians were interested in aspects of tobacco use or
nicotine effects insofar as a model existed for examining a
commonly administered and well understood pharmacological agent.
Analysis of tobacco use provides an opportunity for researchers to
examine behavioral pharmacological mechanisms and perhaps
contribute to the basis for therapeutic intervention.
A substantial data base reflects the fact that smoking behavior,
despite its seeming simplicity, is as varied and as difficult an
analysis problem as most human activities. As this volume attests,
smoking is a complex biobehavioral process and can not be
adequately delineated by any single question or indicator. It has
become apparent that behavioral, physical, and biochemical
indicators must be considered when developing research protocols.
One goal of this discussion will be to further delineate the issues
that must be considered by investigators with diverse goals.
Clinicians and researchers are necessarily consumers of smoking
measurement technology. Depending on the specific areas of study,
much interest lies in evaluating the effectiveness of preventive
and cessation interventions; studying the acquisition and
maintenance processes involved in smoking behavior; or examining
physiological and behavioral correlates of pharmacochemical
effects. The investigator who is implementing intervention
programs attempts to assure that subjects who say they are not
smoking are being truthful. Other investigators are interested in
issues which include the effects of shifts to a lower tar/nicotine
cigarette, the relative reinforcing effectiveness of nicotine,
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individual differences among smokers with respect to disease
states, topography, frequency, metabolism, or other
characteristics. Different questions require emphasis on different
measures, although similarities in requirements do exist.
Much of the material presented in this volume can be organized
around three major questions or areas that concern various segments
of the smoking research community. The first area involves
determination of current smoking or abstinence. This simple
question is for some purposes the most critical issue. The second
issue is related to dosage or exposure to tobacco (nicotine), its
metabolites and tobacco combustion products. This involves the
measurement of tobacco use, including rate, topography, and
chemical intake. The third area involves identifying
characteristics of tobacco users, for example those of the
"dependent smoker." This entails examining physiological and
pharmacological correlates of behavioral patterns and delineating
relationships.
DETERMINING SMOKING AND NONSMOKING
Measuring nonsmoking is the major concern of intervention programs,
be they cessation or prevention. Most have an abstinence focus.
The key dependent variable for evaluation of the intervention
procedure is the proportion of subjects not smoking at a specified
time. Clearly it is equally important to attend to individual data
and assure that they coincide with group differences or
similarities.
Self-report has been a major tool for determining nonsmoking in
intervention studies. Issues of some importance for analysis of
the behavior are those related to patterns and topography.
Obtaining systematic and reliable data can be difficult, but it is
useful for the researcher to determine, for example, whether the
subject's cigarette is smoked "half-way" or to the filter.
Similarly, it is helpful to determine whether cigarette smoking
occurs in bouts or is spaced evenly throughout the day. When
smoking has ceased the appropriate questions must be carefully
stated and the focus of the response must be clearly determined.
Thus, for example, the period of time during which no smoking has
occurred is important whether it be one day, one week, or one
year. Whether a shift from one to another tobacco product has
occurred must be determined. Technical issues in the process can
be resolved if questions are properly devised and if the procedures
for collecting information are carefully implemented.
Truthfulness is a major issue concerning self-reports of both
smoking rates and nonsmoking. Demand characteristics, social
pressure, or incentives for abstinence (Goeckner 1979) may lead
adolescents or adults to deception about their smoking status and
aspects of rate or topography. Objective, chemical measures are
sought to rule out this possibility. Especially useful in this
regard would be a table of the various chemical measures and the
state-of-the-art consensus as to their relative strengths and
weaknesses. Fortunately Benowitz advances toward this goal by
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providing a useful formulation which considers the sensitivity,
costs, and limitations for each of four biological fluids. The
invasiveness of each procedure should be considered as another
comparison dimension. Expired air (carbon monoxide) and saliva
(thiocyanate, nicotine) are easily obtained even in classroom and
nonclinical settings. Urine and blood may be difficult or
impossible to obtain in many field studies. The need for more
invasive procedures differs as a function of the focus of the
study. Clearly no study should be undertaken for which highly
invasive measures are necessary. However, studies should not
preclude use of procedures because of inconvenience or additional
analytical tasks. If appropriate measures are not possible, the
investigators should modify the research question so that
appropriate measures are at their disposal. As was noted in
presentations and discussion, various factors including the need
for medical oversight, the existence of stringent criteria
governing human subject involvement, and increasing budgetary
requirements must be evaluated. Further it must be considered that
one or another study may not be feasible if appropriate measures
can not be obtained.
A relatively simple and inexpensive technique for determining
abstinence is the use of significant others to record data. The
use of others to augment self-report may contribute an extra
measure of validity (e.g., Lichtenstein et al. 1973) but should not
be relied on as infallible, and potential risks of the procedure
must be recognized. Another technique, the so-called "bogus pipe
line," has been reported to increase accuracy of self-report among
adolescents (Evans et al. 1981), but it suffers from potential
ethical problems, as well as confounding of results from a number
of sources.
It is clear, overall, that techniques exist to measure current
rates of smoking and subsequently of abstinence for individuals
involved in smoking research projects. The critical issue is
whether or not the consuming scientist properly uses the available
technology. In this vein, it is equally apparent that even at the
level of abstinence there is a need to utilize the available
chemical analysis techniques if data are to be accepted as valid
and/or reliable.
MEASURING SMOKING OR DOSAGE
The measurement of actual tobacco use as well as the transition to
abstinence can be extremely important for studies intended to
examine diverse issues. Thus, for example, the focus of analysis
might be the behavior of smoking as a case of drug self-
administration, the examination of the physiologic state of
patients with cardiovascular problems, or the effectiveness of a
cessation program. Whatever the purpose, precision in measurement
is an essential adjunct to the study's primary goal. As previously
noted, necessary data can not be ignored simply because they are
difficult to obtain. The question that arises is which data are
necessary or of interest. As indicated in the previous section,
questionnaires can be used to obtain essential data.
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Critical questions concerning type and numbers of cigarettes,
patterns of smoking, and the like must be asked. These questions
should, whenever possible, be derived from other sources (rather
than being developed anew for each study) and should be compatible
with measures used by other researchers. Chemical measures have
clear advantages in verifying gross discrepancies between the
verbal report and actual use levels. The purpose ultimately is to
determine the exposure to products of combustion as well as the
nicotine dosage and their levels in the body in relation to
reported tobacco use. The specific combination of measures may
vary, but breadth of data appears necessary from a health risk
perspective. In addition, it is useful to determine exposure to
those compounds or gases known or believed to be toxic, such as
tars, nicotine, carbon monoxide, and hydrogen cyanide. It is worth
noting that tars seem the most difficult to measure in standard
smoking studies and there is little available information, although
crude physical indicators of tar intake may be used.
The papers in this volume indicate that much progress has been made
in measuring nicotine, cotinine, carbon monoxide, and saliva
thiocyanate, although the task remains complex, On one hand
analysis of obtained fluids reflects levels at a given point. On
the other hand appropriate measures can provide a strong indication
of recent use, and these data can be examined in terms of
self-report measures. Individual differences in rates of intake
and elimination must be considered in estimating overall exposure
levels as well as matters of frequency or recency.
Questionnaire-based smoking rates are the self-report approximation
of exposure or dosage but have the clear disadvantage of
unreliability if they are not linked to objective chemical
measures. However, self-reported rates are convenient for
descriptive or statistical purposes. For example, they permit the
use of more powerful parametric statistical analysis (Lichtenstein
and Danaher 1976). Unfortunately, compared to reports of
abstinence, they are subject to more reporting biases (Pechachek
1979). Self-reported smoking rates tend to be only moderately
correlated with biochemical indicators. This may in part be due to
differences in intake and elimination but also may reside in
erroneous reporting. Nevertheless, it must be remembered that
self-reported rates have been useful in establishing rough
dose-response relationships between smoking and disease.
Concurrently, it must be recalled that further opportunities for
efforts of the magnitude required to establish such statistical
relationships are unlikely to occur.
One major interest in obtaining precise measures of dosage or
intake is to test hypotheses about the nature of smoking behavior
patterns including analysis of titration, or so-called "nicotine
regulation," and the relative reinforcing and aversive properties
of nicotine. Dosage issues may also be of considerable practical
importance in determining aspects of exposure and perhaps in
developing treatment strategies. Plasma cotinine appears to be the
dosage measure of choice for nicotine intake if precision is
required, and it is useful as a marker due to its longer half life.
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Experimental analysis of nicotine regulation and associated
physiological effects requires the capability of manipulating as
well as measuring nicotine intake. The capability to measure
successive puffs or cigarettes in the laboratory provides different
levels of precision for different purposes. Comparison with
standardized nicotine doses administered intravenously indicates
the equivalence of intravenous nicotine to tobacco smoke. This
permits special parallel laboratory studies and provides a basis
for comparison with other drugs. Thus, at this level, the analysis
of smoking serves to verify basic premises about the behavior, the
"product," and the relation to other similarly administered or
similar drugs. Topographical measurement using portable devices in
the natural environment extends the opportunities for further
understanding of smoking and its determinants. Topography measures
can serve as indirect indicators and thus, for example, puff rate,
puff duration, and especially puff volume can contribute to
estimating nicotine intake. Perhaps more important is that these
behavioral measures can serve in examining questions about social
variables and other environmental determinants modulating smoking
behavior. An interesting and possibly useful application for the
new measurement techniques may be in the maintenance of controlled
smoking which has been described as an alternative to abstinence
(Frederiksen and Simon 1978; Foxx and Brown 1979). In these cases
chemical measures of dosage can serve to measure compensation which
maintains nicotine or CD levels in the face of reduced cigarette
consumption. Some (e.g., Frederiksen and Simon) but not all (Foxx
and Brown 1979) controlled smoking studies have included
appropriate measures. Another group for which precision of
topographical measurement is essentially nonexistent is that of
adolescents. The measuring devices could be used to further our
understanding of the intermittent or "unusual" non-chronic patterns
of smoking which often characterize members of this and other
groups. More generally, any studies which report reduction in
smoking rates as a positive outcome should provide chemical
measures of dosage.
Another neglected issue in examining dosage is, of course, the
measurement of smokeless tobacco use. Adult and adolescent use of
these less traditional forms of tobacco is on the rise and an
increasing source of concern (Christen 1980). Plasma nicotine or
cotinine, and probably urinary cotinine, could index use of chewing
or dipping tobacco (Gritz et al. 1981). For adolescents in school
settings,-however, a noninvasive procedure is needed, but none is
currently available. If a subject both smokes cigarettes and uses
chewing tobacco, biochemical measurement of one or the other
becomes very difficult. This is a particular problem for young
adolescents who may be experimenting with both routes of
administration. It also becomes an issue in treatment programs
when alternative routes of use occur after smoking ceases.
MEASURING CHARACTERISTICS OF SMOKERS
Characteristics of smokers may be of interest for several reasons.
The need arises in part to permit comparison of data from different
studies. One of the problems that plagues the field is the
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difficulty of comparing results from different programs since the
comparability of subjects cannot be ascertained. Inherent in this
effort is the need to identify functional subsets of smokers as
defined by smoking patterns and individual characteristics. This
might permit prediction of differential response to different kinds
of interventions.
Considerable disagreement exists concerning the role of personality
or attitudinal variables as determinants of smoking. However,
there is implicit agreement among investigators that smokers vary
in the extent of dependence on pharmacological reinforcing
properties and related behavioral dependence. There has been
little effort to measure this dimension via psychometric or
questionnaire instruments. One possible exception, noted by Lando,
is Fagerstrom's Tolerance Scale (Fagerstrom 1578). This eight-item
measure is fairly crude from a psychometric point of view, but it
appears to have considerable construct validity. The basic idea of
scaling the dependence dimension is worth pursuing, and
Fagerstrom's scale identifies key behaviors that may reflect the
degree of dependence. It should be noted, however, that an
unpublished study by Lichtenstein and his coinvestigators suggests
the scale has weak internal consistency and modest concurrent
validity.
In general, characteristics of smokers can be measured by
combinations of questionnaire instruments and biochemical or
behavioral (topography) measures. Plasma cotinine may be the best
measure of tobacco use although nicotine may reflect acute changes
most accurately. Topographical data, including indicants of
overall patterns (e.g. daily), combined with chemical measures to
validate questionnaire data would likely generate useful
information.
COST-BENEFIT CONSIDERATIONS
The three major questions on areas under discussion may be viewed
as having different measurement requirements. Indeed it might be
argued that each potential hypothesis requires choices with respect
to measurement and the precision required. A cost-benefit
dimension is also involved in the choice of measure. Given the
necessary conceptual and technical base, precision can usually be
obtained, but the cost may be substantial. For example, it is
often a critical measurement goal to assess nicotine dosage. There
is widespread recognition that the number of cigarettes smoked
(assuming that is validly measured) is an imprecise measure.
Knowledge of official nicotine yields of the cigarette smoked
provides little additional information of actual dosage
self-administered.
Although cotinine provides the most precise, valid measure of
nicotine dosage, it is very expensive and moderately invasive since
it requires blood or urine samples. Many investigators, depending
on their hypotheses, may require less precision or may trade some
degree of precision and validity for a less costly or less invasive
measure, such as alveolar carbon monoxide or saliva thiocyanate.
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Similarly some topographical measures are more difficult or more
costly than others, and choices concerning precision will be
necessary. However, it is evident that some effort to verify
questionnaire data through use of chemical and topographical
measures is extremely useful, if not essential.
Problems concerning validation using chemical and topographical
measures exist in many areas of smoking research, but they are
particularly evident in studies of adolescent smoking. Adolescents
present some difficult measurement issues. They tend to smoke
episodically, sometimes trying a few cigarettes, then not smoking
for weeks or months. They also tend to smoke less frequently. In
addition adolescents tend to be less reliable when providing
self-report data. As a group, adolescents thus provide an
excellent example of a case where data collected without
verification may be of limited value.
Unfortunately, biochemical indicators are less sensitive to lower
dosage levels likely to be self-administered by adolescents. It is
not clear that carbon monoxide or thiocyanate levels are useful in
experimental or occasional adolescent smokers except perhaps to
verify infrequent smoking. It is clear that precise noninvasive
techniques are essential for this population and it would be useful
for those engaged in developing biochemical measures to follow
patterns other than those characterized by chronic tobacco use.
Arguments that a chemical measure, despite its insensitivity, might
serve to produce a bogus pipeline effect (Evans et al. 1977) are
not particularly convincing. The bogus pipeline effect may
reassure the investigator, but is probably too fragile and in any
case invokes ethical reservations. In addition its utility will be
reduced as general knowledge of the phenomenon evolves.
In summary, the chapters in this volume provide a useful overview
of strategies and methods for measurement of smoking behavior.
Both the laboratory investigator and the field researcher should
profit from the material herein. It is important to remember that
it was not very long ago that self-report was the only measure of
smoking behavior appearing in the literature. Progress in
measurement has been very substantial and surely will continue.
Both the experimental analysis of smoking behavior and the
evaluation of intervention efforts will profit from such progress.
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drug-receptor interactions.
GPO Stock #017-024-00786-2 $8.00 NTIS PB #292 265/AS $35.50
23 CIGARETTE SMOKING AS A DEPENDENCE PROCESS. Norman A.
Krasnegor, Ph.D., ed. Discusses factors involved in the onset,
maintenance, and cessation of the cigarette smoking habit.
Includes an agenda for future research.
GPO Stock #017-024-00895-8 $6.00 NTIS PB #297 721/AS $19
24 SYNTHETIC ESTIMATES FOR SMALL AREAS: STATISTICAL WORKSHOP
PAPERS AND DISCUSSION. Jos. Steinberg, ed. Papers from a work-
shop on statistical approaches that yield needed estimates of
data for States and local areas. Not available from NCDAI.
GPO Stock #017-024-00911-3 $8.00 NTIS PB #299 009/AS $23.50
25 BEHAVIORAL ANALYSIS AND TREATMENT OF SUBSTANCE ABUSE. Norman
A. Krasnegor, Ph.D., ed. Papers on commonalities and
implications for treatment of dependency on drugs, ethanol, food,
and tobacco.
GPO Stock #017-024-00939-3 $5.00 NTIS PB #80-112428 $22
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26 THE BEHAVIORAL ASPECTS OF SMOKING. Norman A. Krasnegor, Ph.D.,
ed. Reprint of the behavioral section of the 1979 Report of the
Surgeon General on Smoking and Health; introduction by editor.
GPO out of stock NTIS PB #80-118755 $17.50
27 PROBLEMS OF DRUG DEPENDENCE, 1979: PROCEEDINGS OF THE 41ST
ANNUAL SCIENTIFIC MEETING, THE COMMITTEE ON PROBLEMS OF DRUG DE-
PENDENCE, INC. L.S. Harris, Ph.D., ed. Not available from NCDAI.
GPO Stock #017-024-00981-4 $9.00 NTIS PB #80-175482 $37
28 NARCOTIC ANTAGONISTS: NALTREXONE PHARMACOCHEMISTRY AND
SUSTAINED-RELEASE PREPARATIONS. Robert Willette, Ph.D., and
Gene Barnett, Ph.D., eds. Papers report research on sustained-
release and long-acting devices for use with the narcotic antag-
onist naltrexone.
GPO Stock #017-024-01081-2 $7.00 NTIS PB #81-238875 $23.50
29 DRUG ABUSE DEATHS IN NINE CITIES: A SURVEY REPORT. Louis A.
Gottschalk, M.D., et al. Epidemiologic study providing data on
drug-involved deaths and procedures for their investigations.
Not available from NCDAI.
GPO Stock #017-024-00982-2 $6.50 NTIS PB #80-178882 $17.50
30 THEORIES ON DRUG ABUSE: SELECTED CONTEMPORARY PERSPECTIVES.
Dan J. Lettieri, Ph.D.; Mollie Sayers; and Helen Wallenstein
Pearson, eds. Volume presents summaries of the major contem-
porary theories of drug abuse by each of 43 leading theorists.
GPO Stock #017-024-00997-1 $10.00 Not available from NTIS
31 MARIJUANA RESEARCH FINDINGS: 1980. Robert C. Petersen, Ph.D.,
ed. The text of the 8th Marijuana and Health report to Congress
and the background scientific papers on which it was based.
GPO out of stock NTIS PB #80-215171 $20.50
32 GC/MS ASSAYS FOR ABUSED DRUGS IN BODY FLUIDS. Rodger L. Foltz,
Ph.D.; Allison F. Fentiman, Jr., Ph.D.; and Ruth B. Foltz. A
collection of methods for quantitative analysis of several
important drugs of abuse by gas chromatography- mass spectrometry.
GPO Stock #017-024-01015-4 $6.00 NTIS PB #81-133746 $19
33 BENZODIAZEPINES: A REVIEW OF RESEARCH RESULTS, 1980. Stephen
I. Szara, M.D., D.Sc., and Jacqueline P. Ludford, M.S., eds.
A RAUS (Research Analysis and Utilization System) Review Report
on the abuse liability of the benzodiazepine "tranquilizers."
GPO Stock #017-024-01108-8 $5.00 NTIS PB #82-139106 $13
34 PROBLEMS OF DRUG DEPENDENCE, 1980: PROCEEDINGS OF THE 42ND
ANNUAL SCIENTIFIC MEETING, THE COMMITTEE ON PROBLEMS OF DRUG
DEPENDENCE, INC. Louis S. Harris, Ph.D., ed.
GPO Stock #017-024-01061-8 $8.00 NTIS PB #81-194847 $34
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35 DEMOGRAPHIC TRENDS AND DRUG ABUSE, 1980-1995. Louise G.
Richards, Ph.D., ed. Estimates of probable extent and nature of
nonmedical drug use, 1980-1995, based on age structure and other
characteristics of U.S. population.
GPO Stock #017-024-01087-1 $4.50. NTIS PB #82-103417 $13
36 NEW APPROACHES TO TREATMENT OF CHRONIC PAIN: A REVIEW OF MULTI-
DISCIPLINARY PAIN CLINICS AND PAIN CENTERS. Lorenz K.Y. Ng. M.D.,
ed. A sharing of ideas among active practitioners in the treat-
ment of pain.
GPO Stock #017-024-01082-1 $5.50. NTIS PB #81-240913 $19
37 BEHAVIORAL PHARMACOLOGY OF HUMAN DRUG DEPENDENCE. Travis
Thompson, Ph.D., and Chris E. Johanson, Ph.D., eds. Presents a
growing body of data, systematically derived, on the behavioral
mechanisms involved in use and abuse of drugs.
GPO Stock #017-024-01109-6 $6.50 NTIS PB #82-136961 $25
38 DRUG ABUSE AND THE AMERICAN ADOLESCENT. Dan J. Lettieri,
Ph.D., and Jacqueline P. Ludford, M.S., eds. A RAUS Review
Report, emphasizing use of marijuana: epidemiology, socio-
demographic and personality factors, family and peer influence,
delinquency, and biomedical consequences.
GPO Stock #017-024-01107-0 $4.50 NTIS PB #82-148198 $14.50
39 YOUNG MEN AND DRUGS IN MANHATTAN: A CAUSAL ANALYSIS.
Richard R. Clayton, Ph.D., and Harwin L. Voss, Ph.D. Examines
the etiology and natural history of drug use, with special focus
on heroin. Includes a Lifetime Drug Use Index.
GPO Stock #017-024-01097-9 $5.50 NTIS PB #82-147372 $19
40 ADOLESCENT MARIJUANA ABUSERS AND THEIR FAMILIES. Herbert
Hendin, M.D., Ann Pallinger, Ph.D., Richard Ulman, Ph.D., and
Arthur Carr, Ph.D. A psychodynamic study of adolescents
involved in heavy marijuana use, to determine what inter-
action between family and adolescent gives rise to drug abuse.
GPO Stock #017-024-01098-7 $4.50 NTIS PB #82-133117 $13
41 PROBLEMS OF DRUG DEPENDENCE, 1981: PROCEEDINGS OF THE 43RD
ANNUAL SCIENTIFIC MEETING, THE COMMITTEE ON PROBLEMS OF DRUG
DEPENDENCE, INC. Louis S. Harris, Ph.D., ed. A broad review of
current research. Includes treatment issues; chemistry and
pharmacology of abused drugs; efficacy and dependence liability
of new compounds.
Not available from GPO NTIS PB #82-190760 $41.50
42 THE ANALYSIS OF CANNABINOIDS IN BIOLOGICAL FLUIDS. Richard L.
Hawks, Ph.D., ed. Presents varied approaches to sensitive,
reliable, and accessible quantitative assays for the chemical
constituents of marijuana, for basic researchers in biomedical
and forensic science.
GPO Stock #017-024-01151-7 $5 NTIS PB #83-136044 $16
120
43 PROBLEMS OF DRUG DEPENDENCE, 1982: PROCEEDINGS OF THE 44TH
ANNUAL SCIENTIFIC MEETING, THE COMMITTEE ON PROBLEMS OF DRUG
DEPENDENCE. INC. Louis S. Harris. Ph.D.. ed. A collection of
papers which together record a year's advances in drug abuse
research; also includes reports on tests of new compounds for
efficacy and dependence liability.
GPO Stock #017-024-01162-2 $8.50 NTIS PB No. to be assigned
IN PREPARATION
44 MARIJUANA EFFECTS ON THE ENDOCRINE AND REPRODUCTIVE SYSTEMS.
Monique C. Braude, Ph.D., and Jacqueline P. Ludford, M.S., eds.
A RAUS Review Report of animal studies and preclinical and
clinical studies of effects of cannabinoids on human endocrine
and reproductive functions.
45 PAIN MECHANISMS AND MANAGEMENT: A REVIEW OF RESEARCH, 1983.
Roger M. Brown, Ph.D.; Theodore M. Pinkert, M.D., J.D.; and
Jacqueline P. Ludford, M.S., eds. A RAUS Review Report on the
anatomy, physiology, and neurochemistry of pain and its
management.
46 BEHAVIORAL INTERVENTION TECHNIQUES IN DRUG ABUSE TREATMENT.
John Grabowski, Ph.D.; Maxine L. Stitzer, Ph.D., and Jack E.
Henningfield, Ph.D., eds. Reports on a variety of behavioral
contingency management procedures used in research/treatment
environments.
IN PRESS
47 PREVENTING ADOLESCENT DRUG ABUSE: INTERVENTION STRATEGIES.
Thomas J. Glynn, Ph.D.; Carl G. Leukefeld, D.S.W.; and
Jacqueline P. Ludford, M.S., eds. A RAUS Review Report on a
variety of approaches to prevention of adolescent drug abuse, how
they can be applied, their chances for success, and needed future
research.
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